| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.868 | 0.004 | 0.868 | Anticonvulsant | 0.274 0.048 DB03017 0.767 0.004 DBMET02124 0.545 0.009 DB01238 0.333 0.032 DBMET01611 | ||
| 0.7 | 0.006 | 0.7 | Vasodilator, peripheral | 0.671 0.008 DB03017 0.49 0.03 DBMET02124 0.6 0.016 DB01238 0.226 0.148 DBMET00531 0.562 0.02 DBMET01611 | ||
| 0.582 | 0.005 | 0.823 | 5 Hydroxytryptamine 2 antagonist | 0.627 0.004 DBMET02124 0.823 0.003 DB01238 0.713 0.004 DBMET01611 | DB01238 | |
| 0.516 | 0.005 | 0.782 | 5 Hydroxytryptamine 2A antagonist | 0.572 0.004 DBMET02124 0.782 0.003 DB01238 0.671 0.003 DBMET01611 | DB01238 | |
| 0.489 | 0.008 | 0.813 | 5 Hydroxytryptamine antagonist | 0.725 0.004 DBMET02124 0.813 0.004 DB01238 0.675 0.004 DBMET01611 | DB01238 | |
| 0.449 | 0.006 | 0.886 | Dopamine antagonist | 0.78 0.003 DBMET02124 0.886 0.003 DB01238 0.711 0.004 DBMET01611 | DB01238 | |
| 0.451 | 0.016 | 0.512 | Psychostimulant | 0.512 0.01 DB03017 0.212 0.074 DBMET02124 0.372 0.027 DB01238 0.194 0.083 DBMET01611 | DB03017 | |
| 0.441 | 0.006 | 0.896 | Dopamine D2 antagonist | 0.698 0.004 DBMET02124 0.896 0.003 DB01238 0.708 0.004 DBMET01611 | DB01238 | |
| 0.404 | 0.005 | 0.698 | Dopamine agonist | 0.503 0.004 DBMET02124 0.698 0.004 DB01238 0.648 0.004 DBMET01611 | DB01238 | |
| 0.387 | 0.004 | 0.687 | Dopamine D2 agonist | 0.476 0.004 DBMET02124 0.687 0.003 DB01238 0.626 0.003 DBMET01611 | DB01238 | |
| 0.364 | 0.055 | 0.536 | Immunomodulator | 0.536 0.018 DB03017 0.257 0.109 DBMET02124 | DB03017 | |
| 0.285 | 0.004 | 0.513 | Dopamine D3 agonist | 0.346 0.003 DBMET02124 0.513 0.003 DB01238 0.499 0.003 DBMET01611 | DB01238 | |
| 0.249 | 0.008 | 0.491 | Dopamine D1 antagonist | 0.491 0.004 DBMET02124 0.467 0.004 DB01238 0.31 0.005 DBMET01611 | DBMET02124 | |
| 0.218 | 0.006 | 0.442 | Dopamine D4 agonist | 0.325 0.004 DBMET02124 0.442 0.004 DB01238 0.381 0.004 DBMET01611 | DB01238 | |
| 0.217 | 0.015 | 0.779 | 5 Hydroxytryptamine 1 antagonist | 0.304 0.01 DBMET02124 0.779 0.003 DB01238 0.596 0.004 DBMET01611 | DB01238 | |
| 0.211 | 0.016 | 0.617 | 5 Hydroxytryptamine 2C antagonist | 0.259 0.012 DBMET02124 0.617 0.004 DB01238 0.587 0.004 DBMET01611 | DB01238 | |
| 0.22 | 0.024 | 0.81 | Alpha adrenoreceptor antagonist | 0.413 0.009 DBMET02124 0.81 0.003 DB01238 0.536 0.005 DBMET01611 | DB01238 | |
| 0.206 | 0.012 | 0.954 | Dopamine D4 antagonist | 0.42 0.005 DBMET02124 0.954 0.002 DB01238 0.794 0.003 DBMET01611 | DB01238 | |
| 0.211 | 0.022 | 0.437 | Antiadrenergic | 0.299 0.014 DBMET02124 0.437 0.007 DB01238 0.376 0.009 DBMET01611 | DB01238 | |
| 0.208 | 0.022 | 0.434 | Adrenaline antagonist | 0.296 0.014 DBMET02124 0.434 0.007 DB01238 0.372 0.009 DBMET01611 | DB01238 | |
| 0.24 | 0.056 | 0.582 | Platelet aggregation inhibitor | 0.582 0.005 DB03017 0.148 0.13 DBMET02124 0.211 0.074 DB01238 0.211 0.074 DBMET01611 | DB03017 | |
| 0.187 | 0.014 | 0.475 | 5 Hydroxytryptamine 7 antagonist | 0.247 0.008 DBMET02124 0.475 0.005 DB01238 0.448 0.005 DBMET01611 | DB01238 | |
| 0.181 | 0.009 | 0.483 | 5 Hydroxytryptamine 1A agonist | 0.301 0.005 DBMET02124 0.483 0.004 DB01238 0.468 0.004 DBMET01611 | DB01238 | |
| 0.192 | 0.022 | 0.817 | Alpha 1 adrenoreceptor antagonist | 0.383 0.007 DBMET02124 0.817 0.003 DB01238 0.582 0.004 DBMET01611 | DB01238 | |
| 0.278 | 0.115 | 0.475 | Calcium channel activator | 0.365 0.041 DB03017 0.348 0.051 DBMET02124 0.475 0.007 DB01238 0.355 0.046 DBMET00531 0.418 0.019 DBMET01611 | DB01238 | |
| 0.167 | 0.022 | 0.231 | Mediator release inhibitor | 0.231 0.011 DB03017 0.151 0.028 DB01238 0.201 0.014 DBMET01611 | DB03017 | |
| 0.175 | 0.032 | 0.694 | 5 Hydroxytryptamine 2B antagonist | 0.319 0.013 DBMET02124 0.694 0.004 DB01238 0.571 0.004 DBMET01611 | DB01238 | |
| 0.152 | 0.024 | 0.279 | Histamine H1 receptor antagonist | 0.123 0.031 DBMET02124 0.279 0.008 DB01238 0.209 0.013 DBMET01611 | DB01238 | |
| 0.212 | 0.088 | 0.501 | Angiogenesis stimulant | 0.501 0.012 DB03017 | DB03017 | |
| 0.135 | 0.019 | 0.135 | 5 Hydroxytryptamine 1F antagonist | 0.084 0.04 DBMET02124 0.119 0.024 DB01238 0.1 0.031 DBMET01611 | ||
| 0.182 | 0.068 | 0.334 | Sigma receptor agonist | 0.299 0.039 DBMET02124 0.334 0.033 DB01238 0.237 0.051 DBMET01611 | DB01238 | |
| 0.171 | 0.063 | 0.257 | Interleukin 6 antagonist | 0.257 0.022 DB03017 | DB03017 | |
| 0.131 | 0.023 | 0.83 | 5 Hydroxytryptamine 1A antagonist | 0.295 0.009 DBMET02124 0.83 0.003 DB01238 0.628 0.004 DBMET01611 | DB01238 | |
| 0.158 | 0.067 | 0.263 | Acetylcholine M1 receptor antagonist | 0.157 0.068 DB03017 0.166 0.061 DBMET02124 0.263 0.022 DB01238 0.257 0.023 DBMET01611 | DB01238 | |
| 0.182 | 0.093 | 0.381 | Insulin sensitizer | 0.381 0.007 DB03017 0.151 0.132 DBMET00531 | DB03017 | |
| 0.116 | 0.031 | 0.769 | Alpha 1a adrenoreceptor antagonist | 0.314 0.008 DBMET02124 0.769 0.003 DB01238 0.513 0.004 DBMET01611 | DB01238 | |
| 0.104 | 0.022 | 0.104 | Calcium channel L-type blocker | 0.064 0.061 DB03017 0.071 0.051 DBMET02124 0.068 0.055 DB01238 0.071 0.05 DBMET01611 | ||
| 0.201 | 0.12 | 0.52 | Interleukin agonist | 0.52 0.008 DB03017 0.232 0.093 DB01238 0.262 0.07 DBMET00531 | DB03017 | |
| 0.113 | 0.036 | 0.228 | Thioredoxin inhibitor | 0.228 0.006 DB03017 | DB03017 | |
| 0.191 | 0.123 | 0.334 | DNA damaging | 0.334 0.046 DB03017 0.176 0.139 DBMET01611 | DB03017 | |
| 0.135 | 0.068 | 0.21 | Nav1.2 sodium channel blocker | 0.126 0.077 DB03017 0.128 0.074 DBMET02124 0.163 0.05 DB01238 0.21 0.031 DBMET01611 | DBMET01611 | |
| 0.077 | 0.014 | 0.523 | 5 Hydroxytryptamine 7 agonist | 0.115 0.005 DBMET02124 0.523 0.002 DB01238 0.256 0.003 DBMET01611 | DB01238 | |
| 0.084 | 0.024 | 0.371 | 5 Hydroxytryptamine 1 agonist | 0.148 0.014 DBMET02124 0.371 0.005 DB01238 0.361 0.005 DBMET01611 | DB01238 | |
| 0.183 | 0.124 | 0.183 | Tumour necrosis factor alpha release inhibitor | |||
| 0.082 | 0.032 | 0.535 | Dopamine D3 antagonist | 0.157 0.014 DBMET02124 0.535 0.003 DB01238 0.424 0.004 DBMET01611 | DB01238 | |
| 0.054 | 0.007 | 0.696 | Dopamine autoreceptor agonist | 0.114 0.004 DBMET02124 0.696 0.001 DB01238 0.559 0.001 DBMET01611 | DB01238 | |
| 0.173 | 0.128 | 0.424 | Vasodilator | 0.424 0.019 DB03017 0.183 0.119 DB01238 0.154 0.151 DBMET01611 | DB03017 | |
| 0.109 | 0.065 | 0.109 | Interleukin 2 antagonist | |||
| 0.096 | 0.061 | 0.096 | DNA directed RNA polymerase inhibitor | |||
| 0.057 | 0.022 | 0.133 | Oleamide hydrolase inhibitor | 0.067 0.017 DB03017 0.056 0.023 DB01238 0.133 0.005 DBMET01611 | DBMET01611 | |
| 0.15 | 0.118 | 0.167 | P-glycoprotein inhibitor | 0.152 0.114 DB03017 0.138 0.137 DBMET02124 0.167 0.093 DB01238 0.15 0.117 DBMET01611 | DB01238 | |
| 0.13 | 0.1 | 0.385 | Phospholipase A2 inhibitor | 0.385 0.005 DB03017 | DB03017 | |
| 0.206 | 0.179 | 0.267 | Ca(v)3.3 blocker | 0.211 0.169 DBMET02124 0.267 0.077 DB01238 0.262 0.083 DBMET01611 | DB01238 | |
| 0.074 | 0.05 | 0.588 | Alpha 1b adrenoreceptor antagonist | 0.202 0.014 DBMET02124 0.588 0.003 DB01238 0.367 0.005 DBMET01611 | DB01238 | |
| 0.24 | 0.217 | 0.422 | Calcium channel L-type activator | 0.271 0.184 DB03017 0.349 0.118 DBMET02124 0.422 0.067 DB01238 0.262 0.193 DBMET01611 | DB01238 | |
| 0.038 | 0.018 | 0.133 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.133 0.004 DB03017 | DB03017 | |
| 0.07 | 0.054 | 0.1 | Lipase inhibitor | 0.1 0.027 DB03017 | DB03017 | |
| 0.089 | 0.074 | 0.146 | Interleukin 12 antagonist | 0.146 0.014 DB03017 0.113 0.036 DB01238 0.085 0.084 DBMET01611 | DB03017 | |
| 0.06 | 0.046 | 0.173 | 5 Hydroxytryptamine uptake inhibitor | 0.088 0.031 DBMET02124 0.17 0.014 DB01238 0.173 0.013 DBMET01611 | DBMET01611 | |
| 0.1 | 0.087 | 0.149 | Acetylcholine release stimulant | 0.149 0.017 DB03017 0.129 0.036 DBMET00531 | DB03017 | |
| 0.034 | 0.023 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.057 0.003 DB03017 | DB03017 | |
| 0.106 | 0.095 | 0.138 | Acetylcholinesterase inhibitor | 0.138 0.063 DB01238 0.131 0.069 DBMET01611 | DB01238 | |
| 0.041 | 0.031 | 0.069 | Dopamine D5 antagonist | 0.065 0.017 DBMET02124 0.069 0.015 DB01238 0.054 0.023 DBMET01611 | DB01238 | |
| 0.039 | 0.03 | 0.241 | Nicotinic acid receptor 1 agonist | 0.044 0.024 DBMET02124 0.087 0.009 DB01238 0.241 0.003 DBMET01611 | DBMET01611 | |
| 0.073 | 0.067 | 0.073 | Viral attachment inhibitor | |||
| 0.043 | 0.039 | 0.094 | Sigma receptor antagonist | 0.055 0.031 DBMET02124 0.094 0.017 DB01238 0.061 0.027 DBMET01611 | DB01238 | |
| 0.027 | 0.024 | 0.035 | DNA polymerase III inhibitor | 0.027 0.024 DBMET02124 0.032 0.012 DB01238 0.035 0.008 DBMET01611 | DBMET01611 | |
| 0.199 | 0.198 | 0.533 | Immunosuppressant | 0.533 0.025 DB03017 | DB03017 | |
| 0.046 | 0.046 | 0.076 | 5 Hydroxytryptamine 4 antagonist | 0.076 0.015 DB01238 0.06 0.024 DBMET01611 | DB01238 | |
| 0.062 | 0.062 | 0.126 | Amidase inhibitor | 0.103 0.023 DB03017 0.072 0.046 DB01238 0.126 0.014 DBMET01611 | DBMET01611 | |
| 0.056 | 0.059 | 0.296 | 5 Hydroxytryptamine agonist | 0.094 0.035 DBMET02124 0.296 0.008 DB01238 0.242 0.011 DBMET01611 | DB01238 | |
| 0.104 | 0.109 | 0.108 | Calcium channel blocker | 0.108 0.103 DBMET01611 | DBMET01611 | |
| 0.011 | 0.019 | 0.015 | DNA polymerase III polC-type inhibitor | 0.013 0.01 DB01238 0.015 0.006 DBMET01611 | DBMET01611 | |
| 0.229 | 0.239 | 0.414 | Apoptosis agonist | 0.414 0.107 DB03017 | DB03017 | |
| 0.026 | 0.037 | 0.043 | Elastase 3B inhibitor | 0.043 0.007 DB03017 | DB03017 | |
| 0.026 | 0.037 | 0.043 | Elastase 2B inhibitor | 0.043 0.007 DB03017 | DB03017 | |
| 0.026 | 0.037 | 0.043 | Elastase 3A inhibitor | 0.043 0.007 DB03017 | DB03017 | |
| 0.046 | 0.057 | 0.081 | Alpha 1L adrenoreceptor antagonist | 0.054 0.032 DBMET02124 0.068 0.014 DB01238 0.081 0.007 DBMET01611 | DBMET01611 | |
| 0.142 | 0.154 | 0.79 | Platelet antagonist | 0.79 0.004 DB03017 | DB03017 | |
| 0.008 | 0.021 | 0.128 | Prostaglandin EP4 agonist | 0.128 0.003 DB03017 | DB03017 | |
| 0.11 | 0.124 | 0.154 | Cholinergic | 0.154 0.074 DB01238 0.13 0.096 DBMET01611 | DB01238 | |
| 0.046 | 0.061 | 0.33 | Sphingosine 1-phosphate receptor 5 agonist | 0.33 0.003 DB03017 | DB03017 | |
| 0.117 | 0.131 | 0.183 | Neuropeptide Y1 antagonist | 0.125 0.11 DB03017 0.125 0.11 DBMET02124 0.183 0.027 DB01238 0.143 0.075 DBMET01611 | DB01238 | |
| 0.022 | 0.038 | 0.102 | Prostaglandin D2 agonist | 0.102 0.003 DB03017 | DB03017 | |
| 0.009 | 0.026 | 0.096 | 5-Alpha-reductase 1 inhibitor | 0.096 0.005 DB03017 0.018 0.011 DB01238 | DB03017 | |
| 0.043 | 0.06 | 0.081 | 5 Hydroxytryptamine 1B agonist | 0.05 0.042 DBMET02124 0.081 0.012 DB01238 0.079 0.013 DBMET01611 | DB01238 | |
| 0.128 | 0.145 | 0.393 | Lipocortins synthesis antagonist | 0.393 0.009 DB03017 0.16 0.092 DB01238 | DB03017 | |
| 0.047 | 0.067 | 0.081 | Purinergic P2 antagonist | 0.074 0.036 DB01238 0.081 0.032 DBMET01611 | DBMET01611 | |
| 0.124 | 0.144 | 0.465 | Interleukin antagonist | 0.465 0.023 DB03017 | DB03017 | |
| 0.08 | 0.101 | 0.102 | Platelet activating factor antagonist | 0.095 0.083 DB01238 0.102 0.076 DBMET01611 | DBMET01611 | |
| 0.049 | 0.07 | 0.094 | Acetylcholine M5 receptor agonist | 0.064 0.05 DBMET02124 0.093 0.024 DB01238 0.094 0.023 DBMET00531 0.072 0.041 DBMET01611 | DBMET00531 | |
| 0.064 | 0.085 | 0.322 | Cell adhesion molecule inhibitor | 0.322 0.005 DB03017 | DB03017 | |
| 0.022 | 0.043 | 0.118 | Leukotriene A4 hydrolase inhibitor | 0.118 0.005 DB03017 | DB03017 | |
| 0.172 | 0.193 | 0.727 | Cholesterol antagonist | 0.727 0.006 DB03017 0.303 0.089 DBMET00531 | DB03017 | |
| 0.072 | 0.097 | 0.129 | Butyrylcholinesterase inhibitor | 0.129 0.043 DB01238 0.11 0.054 DBMET01611 | DB01238 | |
| 0.055 | 0.08 | 0.157 | Acetylcholine M4 receptor antagonist | 0.157 0.009 DB01238 0.078 0.048 DBMET01611 | DB01238 | |
| 0.082 | 0.108 | 0.191 | Toll-Like receptor 4 antagonist | 0.191 0.008 DB03017 | DB03017 | |
| 0.012 | 0.04 | 0.117 | 5-Alpha-reductase 2 inhibitor | 0.117 0.005 DB03017 | DB03017 | |
| 0.082 | 0.11 | 0.39 | DNA polymerase I inhibitor | 0.39 0.006 DB03017 | DB03017 | |
| 0.028 | 0.057 | 0.086 | GABA uptake inhibitor | 0.086 0.004 DB03017 0.05 0.016 DBMET00531 | DB03017 | |
| 0.021 | 0.051 | 0.145 | 5-Alpha-reductase inhibitor | 0.145 0.007 DB03017 0.139 0.007 DBMET00531 | DB03017 | |
| 0.048 | 0.08 | 0.123 | Leukotriene C antagonist | 0.123 0.003 DB03017 0.055 0.045 DBMET00531 | DB03017 | |
| 0.026 | 0.062 | 0.041 | Delayed rectifier potassium channel blocker | 0.038 0.024 DB03017 0.039 0.023 DB01238 0.036 0.028 DBMET00531 0.041 0.02 DBMET01611 | DBMET01611 | |
| 0.044 | 0.08 | 0.369 | 5 Hydroxytryptamine 1B antagonist | 0.075 0.037 DBMET02124 0.369 0.004 DB01238 0.251 0.006 DBMET01611 | DB01238 | |
| 0.017 | 0.053 | 0.197 | Prostaglandin agonist | 0.197 0.003 DB03017 | DB03017 | |
| 0.095 | 0.131 | 0.26 | Toll-Like receptor antagonist | 0.141 0.062 DB03017 0.144 0.06 DB01238 0.26 0.013 DBMET01611 | DBMET01611 | |
| 0.105 | 0.142 | 0.217 | Farnesoid X receptor antagonist | 0.217 0.017 DB03017 | DB03017 | |
| 0.051 | 0.087 | 0.066 | Potassium channel large-conductance Ca-activated activator | 0.066 0.049 DB03017 | DB03017 | |
| 0.075 | 0.112 | 0.146 | Nav1.1 sodium channel blocker | 0.146 0.035 DB01238 0.118 0.049 DBMET01611 | DB01238 | |
| 0.01 | 0.048 | 0.144 | Prostaglandin E2 agonist | 0.144 0.003 DB03017 | DB03017 | |
| 0.066 | 0.105 | 0.267 | Antihistaminic | 0.267 0.012 DB01238 0.259 0.013 DBMET01611 | DB01238 | |
| 0.037 | 0.079 | 0.047 | CC chemokine receptor 2B antagonist | 0.047 0.037 DBMET01611 | DBMET01611 | |
| 0.031 | 0.075 | 0.387 | Alpha 1d adrenoreceptor antagonist | 0.098 0.024 DBMET02124 0.387 0.004 DB01238 0.191 0.01 DBMET01611 | DB01238 | |
| 0.086 | 0.129 | 0.416 | Cell adhesion inhibitor | 0.416 0.005 DB03017 | DB03017 | |
| 0.023 | 0.068 | 0.138 | Purinergic P2Y antagonist | 0.138 0.005 DB03017 | DB03017 | |
| 0.01 | 0.055 | 0.177 | Purinergic P2Y12 antagonist | 0.177 0.004 DB03017 | DB03017 | |
| 0.158 | 0.203 | 0.297 | Thyroid hormone antagonist | 0.297 0.095 DB03017 0.288 0.1 DBMET02124 0.195 0.166 DB01238 | DB03017 | |
| 0.045 | 0.091 | 0.347 | 5 Hydroxytryptamine 5A antagonist | 0.071 0.03 DBMET02124 0.347 0.004 DB01238 0.25 0.004 DBMET01611 | DB01238 | |
| 0.078 | 0.124 | 0.249 | Alkylator | 0.249 0.017 DB03017 | DB03017 | |
| 0.161 | 0.207 | 0.432 | Gastrin inhibitor | 0.432 0.004 DB03017 0.21 0.134 DB01238 0.253 0.076 DBMET00531 0.268 0.06 DBMET01611 | DB03017 | |
| 0.056 | 0.104 | 0.259 | Histamine antagonist | 0.259 0.012 DB01238 0.253 0.013 DBMET01611 | DB01238 | |
| 0.211 | 0.26 | 0.649 | Cyclophilin D inhibitor | 0.649 0.02 DB03017 | DB03017 | |
| 0.03 | 0.079 | 0.096 | Leukotriene C4 antagonist | 0.096 0.003 DB03017 | DB03017 | |
| 0.083 | 0.134 | 0.557 | Aldehyde dehydrogenase inhibitor | 0.557 0.004 DB03017 0.525 0.004 DBMET00531 | DB03017 | |
| 0.179 | 0.23 | 0.537 | Interleukin 2 agonist | 0.537 0.005 DB03017 0.201 0.188 DB01238 | DB03017 | |
| 0.031 | 0.083 | 0.398 | Prostaglandin EP2 antagonist | 0.398 0.004 DB03017 | DB03017 | |
| 0.137 | 0.192 | 0.179 | Cardiotonic | 0.179 0.141 DB03017 0.177 0.143 DB01238 | DB03017 | |
| 0.005 | 0.06 | 0.118 | Calcium-dependent phospholipase A2 inhibitor | 0.118 0.003 DB03017 | DB03017 | |
| 0.022 | 0.078 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.025 DB03017 | DB03017 | |
| 0.065 | 0.12 | 0.167 | Gastric antisecretory | 0.167 0.02 DB03017 | DB03017 | |
| 0.074 | 0.131 | 0.149 | Acetylcholine muscarinic antagonist | 0.102 0.088 DB03017 0.149 0.044 DB01238 0.137 0.052 DBMET01611 | DB01238 | |
| 0.019 | 0.076 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 DB03017 | DB03017 | |
| 0.017 | 0.075 | 0.038 | Purinergic P2X7 antagonist | 0.038 0.023 DB01238 0.034 0.027 DBMET01611 | DB01238 | |
| 0.077 | 0.135 | 0.139 | Cholinergic antagonist | 0.1 0.096 DB03017 0.139 0.059 DB01238 0.134 0.062 DBMET01611 | DB01238 | |
| 0.045 | 0.104 | 0.08 | Lipocortins synthesis agonist | 0.08 0.013 DB03017 | DB03017 | |
| 0.083 | 0.143 | 0.119 | Estrogen antagonist | 0.119 0.058 DB03017 | DB03017 | |
| 0.07 | 0.134 | 0.108 | Toll-Like receptor 3 antagonist | 0.095 0.058 DB01238 0.108 0.04 DBMET01611 | DBMET01611 | |
| 0.006 | 0.07 | 0.137 | Prostacyclin agonist | 0.137 0.003 DB03017 | DB03017 | |
| 0.022 | 0.086 | 0.094 | Phosphodiesterase 3B inhibitor | 0.086 0.014 DB01238 0.094 0.012 DBMET01611 | DBMET01611 | |
| 0.043 | 0.11 | 0.065 | Bcl2 antagonist | 0.064 0.05 DB01238 0.065 0.048 DBMET01611 | DBMET01611 | |
| 0.04 | 0.107 | 0.24 | Prostaglandin F2 alpha antagonist | 0.24 0.003 DB03017 | DB03017 | |
| 0.035 | 0.103 | 0.307 | Peroxisome proliferator-activated receptor gamma agonist | 0.307 0.005 DB03017 | DB03017 | |
| 0.106 | 0.173 | 0.235 | Sphingosine 1-phosphate receptor 5 antagonist | 0.235 0.004 DB03017 0.157 0.05 DBMET00531 0.129 0.102 DBMET01611 | DB03017 | |
| 0.066 | 0.134 | 0.371 | Alpha 2b adrenoreceptor antagonist | 0.088 0.087 DBMET02124 0.371 0.005 DB01238 0.231 0.018 DBMET01611 | DB01238 | |
| 0.088 | 0.156 | 0.175 | Antibacterial (Helicobacter pylori) | 0.175 0.03 DB03017 | DB03017 | |
| 0.022 | 0.09 | 0.114 | Sphingosine 1-phosphate receptor 1 agonist | 0.114 0.004 DB03017 | DB03017 | |
| 0.016 | 0.084 | 0.254 | Lysophosphatidic acid 2 receptor antagonist | 0.254 0.003 DB03017 0.028 0.026 DBMET00531 | DB03017 | |
| 0.047 | 0.118 | 0.08 | Acetylcholine M3 receptor agonist | 0.08 0.061 DB01238 | DB01238 | |
| 0.062 | 0.132 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.098 0.043 DB03017 0.084 0.069 DB01238 0.104 0.035 DBMET01611 | DBMET01611 | |
| 0.075 | 0.146 | 0.278 | Folate antagonist | 0.278 0.004 DB03017 | DB03017 | |
| 0.005 | 0.079 | 0.119 | Free fatty acid receptor 1 agonist | 0.119 0.004 DB03017 | DB03017 | |
| 0.064 | 0.138 | 0.179 | Lanosterol 14 alpha demethylase inhibitor | 0.179 0.005 DB03017 0.119 0.032 DBMET00531 | DB03017 | |
| 0.02 | 0.095 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 DB03017 0.033 0.029 DBMET00531 0.037 0.022 DBMET01611 | DB03017 | |
| 0.139 | 0.216 | 0.268 | ErbB-1 antagonist | 0.172 0.129 DBMET02124 0.266 0.044 DB01238 0.268 0.044 DBMET01611 | DBMET01611 | |
| 0.096 | 0.173 | 0.266 | Sphingosine 1-phosphate receptor 2 antagonist | 0.266 0.004 DB03017 0.143 0.05 DBMET00531 | DB03017 | |
| 0.037 | 0.115 | 0.288 | 5 Hydroxytryptamine 5 antagonist | 0.058 0.039 DBMET02124 0.288 0.004 DB01238 0.218 0.005 DBMET01611 | DB01238 | |
| 0.031 | 0.109 | 0.283 | 5 Hydroxytryptamine 1D antagonist | 0.283 0.005 DB01238 0.21 0.006 DBMET01611 | DB01238 | |
| 0.007 | 0.087 | 0.03 | Cholecystokinin A agonist | 0.03 0.005 DB03017 | DB03017 | |
| 0.071 | 0.153 | 0.362 | Bone formation stimulant | 0.362 0.012 DB03017 | DB03017 | |
| 0.009 | 0.095 | 0.159 | Leukotriene D4 antagonist | 0.159 0.004 DB03017 | DB03017 | |
| 0.006 | 0.093 | 0.054 | Cholecystokinin agonist | 0.054 0.007 DB03017 | DB03017 | |
| 0.024 | 0.111 | 0.037 | Adenosine uptake inhibitor | 0.037 0.018 DB03017 0.035 0.025 DB01238 0.034 0.026 DBMET00531 | DB03017 | |
| 0.074 | 0.161 | 0.225 | Cyclooxygenase 3 inhibitor | 0.225 0.012 DB03017 0.143 0.055 DBMET00531 | DB03017 | |
| 0.053 | 0.146 | 0.09 | Estrogen receptor alpha antagonist | 0.09 0.035 DB03017 | DB03017 | |
| 0.008 | 0.101 | 0.147 | Leukotriene B4 receptor 1 antagonist | 0.147 0.003 DB03017 | DB03017 | |
| 0.03 | 0.123 | 0.139 | Phosphodiesterase III inhibitor | 0.108 0.019 DB01238 0.139 0.012 DBMET01611 | DBMET01611 | |
| 0.03 | 0.127 | 0.087 | Nitric oxide donor | 0.087 0.016 DB03017 | DB03017 | |
| 0.019 | 0.117 | 0.103 | Aldose reductase inhibitor | 0.103 0.017 DB03017 | DB03017 | |
| 0.019 | 0.117 | 0.141 | Cholecystokinin B agonist | 0.141 0.005 DB03017 | DB03017 | |
| 0.009 | 0.107 | 0.056 | Leukotriene B4 receptor 2 antagonist | 0.056 0.004 DB03017 | DB03017 | |
| 0.144 | 0.244 | 0.258 | Neuropeptide Y2 antagonist | 0.258 0.049 DB03017 0.248 0.058 DB01238 0.191 0.137 DBMET00531 0.211 0.101 DBMET01611 | DB03017 | |
| 0.112 | 0.212 | 0.394 | Spasmolytic | 0.394 0.041 DB03017 0.198 0.121 DBMET02124 0.222 0.104 DB01238 | DB03017 | |
| 0.039 | 0.14 | 0.131 | Calcium antagonist | 0.131 0.029 DB03017 0.082 0.062 DBMET00531 0.084 0.06 DBMET01611 | DB03017 | |
| 0.026 | 0.127 | 0.143 | Acetylcholine M5 receptor antagonist | 0.14 0.009 DB01238 0.143 0.008 DBMET01611 | DBMET01611 | |
| 0.006 | 0.108 | 0.1 | Thyroid hormone alpha antagonist | 0.1 0.004 DB03017 | DB03017 | |
| 0.02 | 0.123 | 0.132 | Sphingosine 1-phosphate receptor agonist | 0.132 0.004 DB03017 | DB03017 | |
| 0.025 | 0.131 | 0.062 | Cholesterol esterase inhibitor | 0.062 0.016 DB03017 | DB03017 | |
| 0.015 | 0.121 | 0.052 | Cannabinoid CB2 receptor antagonist | 0.052 0.035 DBMET01611 | DBMET01611 | |
| 0.012 | 0.12 | 0.051 | Carnitine palmitoyltransferase inhibitor | 0.051 0.008 DB03017 | DB03017 | |
| 0.026 | 0.134 | 0.058 | Integrin alpha1beta1 antagonist | 0.058 0.005 DB03017 | DB03017 | |
| 0.026 | 0.134 | 0.093 | Acetyl-CoA transferase inhibitor | 0.093 0.016 DB03017 | DB03017 | |
| 0.013 | 0.122 | 0.048 | Carnitine palmitoyltransferase 1 inhibitor | 0.048 0.009 DB03017 | DB03017 | |
| 0.019 | 0.128 | 0.061 | p53 inhibitor | 0.061 0.009 DB03017 | DB03017 | |
| 0.057 | 0.169 | 0.091 | Estrogen receptor beta antagonist | 0.091 0.082 DB03017 | DB03017 | |
| 0.061 | 0.173 | 0.137 | Acetylcholine antagonist | 0.137 0.058 DB01238 0.133 0.06 DBMET01611 | DB01238 | |
| 0.002 | 0.115 | 0.079 | Thromboxane agonist | 0.079 0.002 DB03017 | DB03017 | |
| 0.197 | 0.312 | 0.626 | 5 Hydroxytryptamine release inhibitor | 0.626 0.008 DB03017 0.402 0.077 DB01238 0.464 0.046 DBMET00531 0.469 0.044 DBMET01611 | DB03017 | |
| 0.021 | 0.135 | 0.05 | Acetyl-CoA transferase 1 inhibitor | 0.05 0.017 DB03017 | DB03017 | |
| 0.008 | 0.123 | 0.099 | Cholecystokinin antagonist | 0.099 0.008 DB03017 | DB03017 | |
| 0.006 | 0.121 | 0.106 | Prostaglandin EP2 agonist | 0.106 0.003 DB03017 | DB03017 | |
| 0.115 | 0.232 | 0.393 | Cyclic AMP phosphodiesterase inhibitor | 0.324 0.033 DB03017 0.393 0.018 DB01238 0.17 0.122 DBMET00531 0.371 0.021 DBMET01611 | DB01238 | |
| 0.036 | 0.155 | 0.325 | Alpha 2a adrenoreceptor antagonist | 0.325 0.006 DB01238 0.213 0.012 DBMET01611 | DB01238 | |
| 0.037 | 0.157 | 0.084 | Adenine nucleotide translocase inhibitor | 0.084 0.008 DB03017 | DB03017 | |
| 0.06 | 0.18 | 0.195 | Hematopoietic | 0.195 0.01 DB03017 0.094 0.043 DBMET02124 | DB03017 | |
| 0.021 | 0.141 | 0.259 | Plasminogen activator inhibitor antagonist | 0.259 0.004 DB03017 | DB03017 | |
| 0.029 | 0.15 | 0.059 | Adrenaline uptake inhibitor | 0.059 0.045 DB01238 0.055 0.05 DBMET01611 | DB01238 | |
| 0.005 | 0.126 | 0.118 | Prostaglandin EP3 antagonist | 0.118 0.005 DB03017 | DB03017 | |
| 0.015 | 0.136 | 0.152 | Peroxisome proliferator-activated receptor delta antagonist | 0.152 0.005 DB03017 | DB03017 | |
| 0.015 | 0.139 | 0.182 | Glycine transporter 2 inhibitor | 0.182 0.006 DB03017 | DB03017 | |
| 0.008 | 0.133 | 0.03 | Elastase 2 inhibitor | 0.03 0.009 DB03017 | DB03017 | |
| 0.008 | 0.133 | 0.03 | Elastase 2A inhibitor | 0.03 0.009 DB03017 | DB03017 | |
| 0.093 | 0.218 | 0.14 | Tumour necrosis factor antagonist | 0.14 0.114 DB03017 | DB03017 | |
| 0.072 | 0.198 | 0.196 | Interleukin 8 antagonist | 0.196 0.014 DB03017 | DB03017 | |
| 0.024 | 0.15 | 0.066 | Aminopeptidase microsomal inhibitor | 0.066 0.034 DB03017 | DB03017 | |
| 0.028 | 0.157 | 0.163 | Alpha adrenoreceptor agonist | 0.163 0.014 DB01238 0.086 0.034 DBMET01611 | DB01238 | |
| 0.005 | 0.135 | 0.06 | Cholecystokinin B antagonist | 0.06 0.009 DB03017 | DB03017 | |
| 0.12 | 0.25 | 0.267 | Thyroid hormone beta antagonist | 0.267 0.107 DB03017 0.193 0.16 DB01238 | DB03017 | |
| 0.051 | 0.181 | 0.265 | Alpha 2c adrenoreceptor antagonist | 0.265 0.009 DB01238 0.17 0.025 DBMET01611 | DB01238 | |
| 0.038 | 0.171 | 0.235 | Alpha 2 adrenoreceptor antagonist | 0.235 0.013 DB01238 0.146 0.028 DBMET01611 | DB01238 | |
| 0.04 | 0.173 | 0.254 | Interferon agonist | 0.254 0.004 DB03017 0.081 0.051 DBMET00531 | DB03017 | |
| 0.052 | 0.186 | 0.148 | EphA2 antagonist | 0.141 0.036 DB01238 0.148 0.031 DBMET01611 | DBMET01611 | |
| 0.045 | 0.18 | 0.177 | Sphingomyelinase inhibitor | 0.177 0.015 DB03017 0.113 0.047 DBMET00531 | DB03017 | |
| 0.082 | 0.218 | 0.59 | Anesthetic general | 0.59 0.005 DB03017 0.227 0.061 DBMET00531 | DB03017 | |
| 0.045 | 0.181 | 0.112 | Antineoplastic alkaloid | 0.112 0.041 DB03017 | DB03017 | |
| 0.009 | 0.147 | 0.03 | Retinoic acid beta receptor agonist | 0.03 0.005 DB03017 | DB03017 | |
| 0.007 | 0.146 | 0.019 | Corticosteroid-like | 0.019 0.018 DB03017 | DB03017 | |
| 0.016 | 0.156 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.034 DB03017 | DB03017 | |
| 0.02 | 0.16 | 0.18 | Alpha 1 adrenoreceptor agonist | 0.052 0.048 DBMET02124 0.18 0.007 DB01238 0.105 0.015 DBMET01611 | DB01238 | |
| 0.076 | 0.216 | 0.228 | Sphingosine 1-phosphate receptor 4 antagonist | 0.228 0.005 DB03017 0.125 0.064 DBMET00531 | DB03017 | |
| 0.041 | 0.182 | 0.181 | Anesthetic local | 0.181 0.037 DB03017 | DB03017 | |
| 0.01 | 0.152 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DB03017 | DB03017 | |
| 0.191 | 0.334 | 0.799 | Caspase 9 stimulant | 0.799 0.011 DB03017 0.272 0.226 DB01238 0.429 0.095 DBMET00531 0.252 0.251 DBMET01611 | DB03017 | |
| 0.019 | 0.162 | 0.056 | Acetylcholine M2 receptor antagonist | 0.056 0.048 DB01238 | DB01238 | |
| 0.089 | 0.234 | 0.551 | Hypolipemic | 0.551 0.009 DB03017 | DB03017 | |
| 0.005 | 0.151 | 0.071 | Squalene synthetase inhibitor | 0.071 0.009 DB03017 | DB03017 | |
| 0.006 | 0.154 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET00531 | DBMET00531 | |
| 0.022 | 0.17 | 0.051 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.028 DB03017 | DB03017 | |
| 0.052 | 0.201 | 0.164 | Nav1.3 sodium channel blocker | 0.116 0.078 DB03017 0.149 0.048 DB01238 0.164 0.039 DBMET01611 | DBMET01611 | |
| 0.008 | 0.157 | 0.115 | Prostaglandin EP4 antagonist | 0.115 0.004 DB03017 | DB03017 | |
| 0.142 | 0.293 | 0.61 | Apoptosis antagonist | 0.61 0.009 DB03017 | DB03017 | |
| 0.017 | 0.168 | 0.045 | Purinergic P2X antagonist | 0.045 0.038 DB01238 0.045 0.038 DBMET01611 | DBMET01611 | |
| 0.041 | 0.193 | 0.112 | ErbB-3 antagonist | 0.112 0.033 DB03017 | DB03017 | |
| 0.015 | 0.167 | 0.092 | Adenosine deaminase inhibitor | 0.092 0.007 DB03017 0.054 0.026 DBMET00531 | DB03017 | |
| 0.033 | 0.185 | 0.308 | NMDA receptor antagonist | 0.113 0.039 DB03017 0.308 0.006 DB01238 0.244 0.01 DBMET01611 | DB01238 | |
| 0.06 | 0.213 | 0.195 | Glutamate release inhibitor | 0.195 0.005 DB03017 0.124 0.019 DBMET00531 | DB03017 | |
| 0.192 | 0.345 | 0.579 | Antiinflammatory | 0.579 0.059 DB03017 | DB03017 | |
| 0.113 | 0.27 | 0.287 | MAP-kinase-activated kinase 5 inhibitor | 0.164 0.158 DBMET02124 0.25 0.059 DB01238 0.287 0.037 DBMET01611 | DBMET01611 | |
| 0.129 | 0.286 | 0.611 | Antithrombotic | 0.611 0.015 DB03017 | DB03017 | |
| 0.043 | 0.201 | 0.1 | Bronchodilator | 0.1 0.064 DB03017 | DB03017 | |
| 0.003 | 0.161 | 0.106 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.106 0.003 DB03017 | DB03017 | |
| 0.021 | 0.185 | 0.052 | Protein kinase C eta inhibitor | 0.052 0.042 DBMET02124 | DBMET02124 | |
| 0.052 | 0.218 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.054 DB03017 | DB03017 | |
| 0.067 | 0.233 | 0.423 | Protein kinase stimulant | 0.423 0.007 DB03017 0.128 0.085 DBMET00531 | DB03017 | |
| 0.005 | 0.172 | 0.087 | Sphingosine 1-phosphate receptor 3 agonist | 0.087 0.008 DB03017 | DB03017 | |
| 0.054 | 0.225 | 0.076 | Ca(v)3.1 blocker | 0.076 0.073 DBMET01611 | DBMET01611 | |
| 0.131 | 0.304 | 0.245 | Antiobesity | 0.245 0.162 DB03017 | DB03017 | |
| 0.025 | 0.199 | 0.16 | Thromboxane synthase inhibitor | 0.16 0.004 DB03017 | DB03017 | |
| 0.012 | 0.187 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DB03017 | DB03017 | |
| 0.05 | 0.226 | 0.117 | Interleukin 5 antagonist | 0.117 0.026 DB03017 | DB03017 | |
| 0.05 | 0.228 | 0.268 | Lipid peroxidase inhibitor | 0.268 0.024 DB03017 | DB03017 | |
| 0.008 | 0.188 | 0.032 | Retinoic acid receptor agonist | 0.032 0.009 DB03017 | DB03017 | |
| 0.005 | 0.185 | 0.088 | Cholecystokinin A antagonist | 0.088 0.011 DB03017 | DB03017 | |
| 0.015 | 0.196 | 0.053 | Retinoic acid alpha receptor agonist | 0.053 0.012 DB03017 | DB03017 | |
| 0.05 | 0.232 | 0.163 | ABCA1 expression enhancer | 0.163 0.014 DB03017 | DB03017 | |
| 0.018 | 0.2 | 0.042 | Microtubule stabilization | 0.042 0.038 DB03017 | DB03017 | |
| 0.052 | 0.234 | 0.18 | Nav1.4 sodium channel blocker | 0.18 0.024 DB03017 | DB03017 | |
| 0.107 | 0.291 | 0.238 | Ca2+-transporting ATPase inhibitor | 0.238 0.002 DB03017 0.187 0.005 DBMET00531 | DB03017 | |
| 0.004 | 0.192 | 0.025 | Angiotensin AT1A receptor antagonist | 0.025 0.009 DB03017 | DB03017 | |
| 0.004 | 0.194 | 0.021 | Endothelin B receptor antagonist | 0.021 0.012 DB03017 | DB03017 | |
| 0.004 | 0.197 | 0.099 | Purinergic P2T antagonist | 0.099 0.005 DB03017 | DB03017 | |
| 0.1 | 0.294 | 0.323 | Catenin beta inhibitor | 0.323 0.005 DB03017 | DB03017 | |
| 0.059 | 0.254 | 0.254 | Interleukin 4 antagonist | 0.254 0.013 DB03017 | DB03017 | |
| 0.005 | 0.2 | 0.077 | Histamine H3 receptor antagonist | 0.056 0.023 DB01238 0.077 0.017 DBMET01611 | DBMET01611 | |
| 0.017 | 0.212 | 0.044 | Neurokinin 2 agonist | 0.044 0.025 DB03017 | DB03017 | |
| 0.037 | 0.232 | 0.162 | Sphingosine 1-phosphate receptor antagonist | 0.162 0.005 DB03017 | DB03017 | |
| 0.076 | 0.272 | 0.453 | Immunostimulant | 0.453 0.036 DB03017 | DB03017 | |
| 0.024 | 0.221 | 0.075 | Autotaxin inhibitor | 0.075 0.02 DB03017 | DB03017 | |
| 0.011 | 0.209 | 0.074 | Cannabinoid CB1 receptor agonist | 0.074 0.032 DB03017 | DB03017 | |
| 0.064 | 0.263 | 0.128 | MAP3K9 inhibitor | 0.128 0.099 DB01238 | DB01238 | |
| 0.018 | 0.217 | 0.08 | Glutamate (mGluR8) antagonist | 0.08 0.004 DB03017 | DB03017 | |
| 0.069 | 0.269 | 0.213 | Potassium channel blocker | 0.199 0.093 DB01238 0.213 0.084 DBMET01611 | DBMET01611 | |
| 0.012 | 0.212 | 0.039 | Caspase 6 inhibitor | 0.039 0.009 DB03017 | DB03017 | |
| 0.074 | 0.277 | 0.519 | Growth hormone agonist | 0.519 0.005 DB03017 | DB03017 | |
| 0.009 | 0.213 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.021 DB03017 | DB03017 | |
| 0.011 | 0.216 | 0.117 | Prostaglandin E2 antagonist | 0.117 0.012 DB03017 | DB03017 | |
| 0.129 | 0.334 | 0.592 | GABA C receptor rho-3 antagonist | 0.586 0.009 DB03017 0.294 0.12 DB01238 0.592 0.008 DBMET00531 0.427 0.05 DBMET01611 | DBMET00531 | |
| 0.006 | 0.213 | 0.127 | Prostacyclin antagonist | 0.127 0.004 DB03017 | DB03017 | |
| 0.031 | 0.237 | 0.164 | Adrenaline agonist | 0.079 0.058 DB03017 0.131 0.021 DB01238 0.164 0.012 DBMET01611 | DBMET01611 | |
| 0.018 | 0.226 | 0.198 | Leukotriene antagonist | 0.198 0.006 DB03017 | DB03017 | |
| 0.089 | 0.297 | 0.588 | Phospholipase C inhibitor | 0.588 0.004 DB03017 0.18 0.061 DBMET00531 | DB03017 | |
| 0.008 | 0.217 | 0.031 | Liver X receptor beta agonist | 0.031 0.026 DB03017 | DB03017 | |
| 0.073 | 0.282 | 0.45 | Insulin secretagoues | 0.45 0.005 DB03017 | DB03017 | |
| 0.03 | 0.239 | 0.161 | Interferon inducer | 0.161 0.004 DB03017 0.067 0.039 DBMET00531 | DB03017 | |
| 0.006 | 0.216 | 0.059 | Kainate receptor 4 antagonist | 0.059 0.005 DB03017 | DB03017 | |
| 0.067 | 0.279 | 0.15 | Antimitotic | 0.15 0.121 DBMET02124 | DBMET02124 | |
| 0.07 | 0.283 | 0.375 | Platelet adhesion inhibitor | 0.375 0.015 DB03017 | DB03017 | |
| 0.016 | 0.234 | 0.055 | Dopamine uptake inhibitor | 0.055 0.043 DBMET01611 | DBMET01611 | |
| 0.112 | 0.331 | 0.396 | Vasodilator, coronary | 0.396 0.037 DB03017 0.291 0.095 DB01238 0.249 0.136 DBMET00531 0.239 0.145 DBMET01611 | DB03017 | |
| 0.029 | 0.248 | 0.12 | Macrophage migration inhibitory factor inhibitor | 0.12 0.025 DB03017 | DB03017 | |
| 0.02 | 0.241 | 0.216 | Leukotriene synthesis inhibitor | 0.216 0.005 DB03017 | DB03017 | |
| 0.016 | 0.24 | 0.111 | Glucagon-like peptide 1 agonist | 0.111 0.017 DB03017 | DB03017 | |
| 0.008 | 0.233 | 0.147 | Peroxisome proliferator-activated receptor alpha agonist | 0.147 0.006 DB03017 | DB03017 | |
| 0.007 | 0.233 | 0.043 | 5 Hydroxytryptamine 2C agonist | 0.043 0.034 DB01238 | DB01238 | |
| 0.013 | 0.241 | 0.055 | Erythropoietin receptor agonist | 0.055 0.019 DB03017 | DB03017 | |
| 0.011 | 0.239 | 0.079 | Leukocyte elastase inhibitor | 0.079 0.013 DB03017 | DB03017 | |
| 0.014 | 0.244 | 0.052 | 5 Hydroxytryptamine 3 antagonist | 0.052 0.045 DB01238 | DB01238 | |
| 0.023 | 0.254 | 0.083 | Beta adrenoreceptor antagonist | 0.083 0.025 DB03017 0.059 0.058 DBMET01611 | DB03017 | |
| 0.004 | 0.235 | 0.147 | Prostaglandin D2 antagonist | 0.147 0.004 DB03017 | DB03017 | |
| 0.033 | 0.266 | 0.318 | Cholesterol synthesis inhibitor | 0.318 0.01 DB03017 0.124 0.061 DBMET00531 | DB03017 | |
| 0.007 | 0.241 | 0.073 | AMPA 2 receptor antagonist | 0.073 0.008 DB03017 | DB03017 | |
| 0.011 | 0.245 | 0.378 | Prostaglandin antagonist | 0.378 0.004 DB03017 | DB03017 | |
| 0.033 | 0.269 | 0.303 | Creatine kinase inhibitor | 0.303 0.004 DB03017 0.2 0.01 DBMET00531 0.105 0.054 DBMET01611 | DB03017 | |
| 0.002 | 0.238 | 0.077 | G-protein-coupled receptor 120 agonist | 0.077 0.003 DB03017 | DB03017 | |
| 0.02 | 0.257 | 0.073 | Nav1.8 sodium channel blocker | 0.073 0.052 DBMET01611 | DBMET01611 | |
| 0.016 | 0.254 | 0.057 | Thymidine kinase inhibitor | 0.057 0.015 DB03017 0.044 0.024 DBMET00531 | DB03017 | |
| 0.004 | 0.243 | 0.197 | GP IIb/IIIa receptor antagonist | 0.197 0.007 DB03017 | DB03017 | |
| 0.064 | 0.303 | 0.184 | Nitric oxide antagonist | 0.184 0.074 DB03017 | DB03017 | |
| 0.048 | 0.288 | 0.169 | Electron transport complex I inhibitor | 0.169 0.013 DB03017 | DB03017 | |
| 0.008 | 0.25 | 0.028 | Retinoic acid gamma receptor agonist | 0.028 0.008 DB03017 | DB03017 | |
| 0.058 | 0.3 | 0.346 | HERG channel blocker | 0.29 0.052 DB01238 0.346 0.038 DBMET01611 | DBMET01611 | |
| 0.022 | 0.268 | 0.128 | Elastase 1 inhibitor | 0.128 0.01 DB03017 | DB03017 | |
| 0.01 | 0.256 | 0.053 | Acetylcholine M3 receptor antagonist | 0.053 0.05 DB01238 | DB01238 | |
| 0.014 | 0.26 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 DBMET02124 | DBMET02124 | |
| 0.008 | 0.255 | 0.055 | Phosphorylase inhibitor | 0.055 0.028 DB03017 | DB03017 | |
| 0.007 | 0.255 | 0.04 | Retinoid X gamma receptor antagonist | 0.04 0.005 DB03017 | DB03017 | |
| 0.021 | 0.269 | 0.101 | Platelet growth factor antagonist | 0.077 0.059 DB01238 0.101 0.04 DBMET01611 | DBMET01611 | |
| 0.02 | 0.269 | 0.103 | Glucagon-like peptide 1 receptor antagonist | 0.103 0.005 DB03017 | DB03017 | |
| 0.045 | 0.293 | 0.194 | Neurotrophic factor | 0.194 0.03 DB03017 | DB03017 | |
| 0.073 | 0.323 | 0.362 | Interferon gamma antagonist | 0.362 0.013 DB03017 0.171 0.056 DBMET00531 | DB03017 | |
| 0.059 | 0.309 | 0.329 | Potassium channel (Voltage-sensitive) blocker | 0.298 0.05 DB01238 0.329 0.041 DBMET01611 | DBMET01611 | |
| 0.002 | 0.255 | 0.076 | Peroxisome proliferator-activated receptor alpha antagonist | 0.076 0.005 DB03017 | DB03017 | |
| 0.092 | 0.345 | 0.424 | DNA synthesis inhibitor | 0.424 0.019 DB03017 0.26 0.06 DBMET00531 | DB03017 | |
| 0.022 | 0.276 | 0.207 | CDC25A inhibitor | 0.207 0.006 DB03017 | DB03017 | |
| 0.017 | 0.272 | 0.265 | Sphingosine 1-phosphate receptor 4 agonist | 0.265 0.003 DB03017 0.07 0.044 DBMET00531 | DB03017 | |
| 0.021 | 0.279 | 0.053 | CXC chemokine 1 receptor antagonist | 0.053 0.032 DB03017 | DB03017 | |
| 0.021 | 0.279 | 0.154 | Sphingosine 1-phosphate receptor 1 antagonist | 0.154 0.004 DB03017 | DB03017 | |
| 0.005 | 0.262 | 0.033 | Kainate receptor 3 antagonist | 0.033 0.005 DB03017 | DB03017 | |
| 0.02 | 0.279 | 0.07 | Squalene epoxidase inhibitor | 0.07 0.014 DB03017 0.056 0.025 DBMET00531 | DB03017 | |
| 0.026 | 0.286 | 0.137 | Histamine N-methyltransferase inhibitor | 0.097 0.049 DB03017 0.126 0.026 DB01238 0.112 0.035 DBMET00531 0.137 0.019 DBMET01611 | DBMET01611 | |
| 0.007 | 0.267 | 0.091 | Prostaglandin F2 alpha agonist | 0.091 0.002 DB03017 0.024 0.014 DBMET00531 | DB03017 | |
| 0.028 | 0.288 | 0.085 | Beta 3 adrenoreceptor antagonist | 0.085 0.02 DB03017 0.063 0.048 DB01238 0.066 0.041 DBMET01611 | DB03017 | |
| 0.052 | 0.316 | 0.202 | Histone deacetylase SIRT1 inhibitor | 0.202 0.029 DB03017 | DB03017 | |
| 0.005 | 0.268 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 DB03017 | DB03017 | |
| 0.013 | 0.276 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 DB03017 | DB03017 | |
| 0.021 | 0.284 | 0.143 | Phospholipase D inhibitor | 0.143 0.004 DB03017 0.099 0.015 DBMET00531 0.074 0.045 DBMET01611 | DB03017 | |
| 0.004 | 0.268 | 0.049 | Kainate receptor 5 antagonist | 0.049 0.005 DB03017 | DB03017 | |
| 0.071 | 0.335 | 0.354 | Antioxidant | 0.354 0.045 DB03017 | DB03017 | |
| 0.018 | 0.284 | 0.076 | Angiotensin-converting enzyme inhibitor | 0.076 0.016 DB03017 | DB03017 | |
| 0.012 | 0.28 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 DB03017 0.028 0.014 DBMET00531 | DBMET00531 | |
| 0.081 | 0.35 | 0.529 | Hypoglycemic | 0.529 0.013 DB03017 | DB03017 | |
| 0.033 | 0.304 | 0.116 | Protein kinase C gamma inhibitor | 0.102 0.073 DB03017 0.104 0.069 DBMET02124 0.106 0.068 DB01238 0.116 0.056 DBMET01611 | DBMET01611 | |
| 0.024 | 0.295 | 0.089 | Phosphodiesterase 3A inhibitor | 0.074 0.065 DB01238 0.089 0.043 DBMET01611 | DBMET01611 | |
| 0.008 | 0.279 | 0.029 | Liver X receptor antagonist | 0.029 0.024 DB03017 | DB03017 | |
| 0.006 | 0.278 | 0.025 | Urotensin II agonist | 0.025 0.021 DB03017 | DB03017 | |
| 0.017 | 0.29 | 0.103 | Cannabinoid receptor antagonist | 0.103 0.028 DBMET01611 | DBMET01611 | |
| 0.015 | 0.291 | 0.445 | Catalase inhibitor | 0.445 0.003 DB03017 0.35 0.005 DBMET00531 | DB03017 | |
| 0.005 | 0.281 | 0.103 | Peroxisome proliferator-activated receptor delta agonist | 0.103 0.005 DB03017 | DB03017 | |
| 0.013 | 0.289 | 0.171 | Lysophosphatidic acid 3 receptor antagonist | 0.171 0.002 DB03017 0.063 0.019 DBMET00531 | DB03017 | |
| 0.014 | 0.295 | 0.129 | 5 Hydroxytryptamine 2A agonist | 0.129 0.008 DB01238 0.112 0.011 DBMET01611 | DB01238 | |
| 0.004 | 0.289 | 0.042 | Endothelin receptor antagonist | 0.042 0.012 DB03017 | DB03017 | |
| 0.032 | 0.317 | 0.161 | Uric acid excretion stimulant | 0.161 0.02 DB03017 | DB03017 | |
| 0.004 | 0.29 | 0.084 | Vitronectin receptor antagonist | 0.084 0.005 DB03017 | DB03017 | |
| 0.014 | 0.301 | 0.074 | Beta 1 adrenoreceptor antagonist | 0.074 0.022 DB03017 | DB03017 | |
| 0.004 | 0.292 | 0.024 | Endothelin A receptor antagonist | 0.024 0.013 DB03017 | DB03017 | |
| 0.005 | 0.293 | 0.059 | HMG CoA reductase inhibitor | 0.059 0.005 DB03017 | DB03017 | |
| 0.009 | 0.297 | 0.207 | Toll-Like receptor 2 agonist | 0.207 0.007 DB03017 0.038 0.031 DBMET00531 | DB03017 | |
| 0.027 | 0.322 | 0.097 | Ryanodine receptor antagonist | 0.097 0.004 DB03017 0.069 0.018 DBMET00531 | DB03017 | |
| 0.028 | 0.327 | 0.123 | Peroxisome proliferator-activated receptor gamma antagonist | 0.123 0.009 DB03017 | DB03017 | |
| 0.018 | 0.318 | 0.079 | Acetyl-CoA transferase 2 inhibitor | 0.079 0.011 DB03017 | DB03017 | |
| 0.034 | 0.336 | 0.166 | Bile acid receptor antagonist | 0.166 0.005 DB03017 0.091 0.072 DBMET00531 | DB03017 | |
| 0.032 | 0.335 | 0.143 | GABA receptor agonist | 0.143 0.04 DB03017 | DB03017 | |
| 0.023 | 0.326 | 0.047 | Heme oxygenase inhibitor | 0.046 0.02 DB03017 0.047 0.018 DBMET00531 | DBMET00531 | |
| 0.009 | 0.313 | 0.153 | Thromboxane antagonist | 0.153 0.004 DB03017 | DB03017 | |
| 0.011 | 0.316 | 0.204 | Selectin antagonist | 0.204 0.011 DB03017 | DB03017 | |
| 0.005 | 0.312 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 DB03017 | DB03017 | |
| 0.004 | 0.313 | 0.134 | Kainate receptor 2 antagonist | 0.134 0.004 DB03017 | DB03017 | |
| 0.007 | 0.317 | 0.141 | Thromboxane A2 antagonist | 0.141 0.004 DB03017 | DB03017 | |
| 0.019 | 0.33 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 DB03017 | DB03017 | |
| 0.098 | 0.411 | 0.661 | Histamine release inhibitor | 0.661 0.006 DB03017 0.217 0.183 DB01238 0.37 0.09 DBMET00531 0.207 0.194 DBMET01611 | DB03017 | |
| 0.01 | 0.323 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.012 DB03017 0.032 0.013 DBMET00531 | DBMET00531 | |
| 0.031 | 0.348 | 0.421 | Thrombolytic | 0.421 0.009 DB03017 | DB03017 | |
| 0.05 | 0.369 | 0.312 | DNA methyltransferase I inhibitor | 0.312 0.022 DB03017 0.152 0.101 DBMET01611 | DB03017 | |
| 0.029 | 0.348 | 0.141 | Caspase 9 inhibitor | 0.141 0.007 DB03017 | DB03017 | |
| 0.018 | 0.339 | 0.098 | Cyclin B3 inhibitor | 0.098 0.029 DB01238 0.082 0.037 DBMET01611 | DB01238 | |
| 0.013 | 0.334 | 0.081 | 5 Hydroxytryptamine 3A antagonist | 0.08 0.031 DB01238 0.081 0.03 DBMET01611 | DBMET01611 | |
| 0.039 | 0.361 | 0.321 | Toll-Like receptor 2 antagonist | 0.321 0.004 DB03017 0.14 0.059 DBMET00531 | DB03017 | |
| 0.012 | 0.337 | 0.157 | Leukotriene B4 antagonist | 0.157 0.005 DB03017 | DB03017 | |
| 0.01 | 0.336 | 0.039 | Liver X receptor alpha agonist | 0.039 0.032 DB03017 | DB03017 | |
| 0.037 | 0.364 | 0.111 | Nav1.5 sodium channel blocker | 0.107 0.072 DB01238 0.111 0.067 DBMET01611 | DBMET01611 | |
| 0.007 | 0.336 | 0.166 | ATP citrate lysase inhibitor | 0.166 0.003 DB03017 0.029 0.026 DBMET00531 | DB03017 | |
| 0.06 | 0.391 | 0.278 | 5 Hydroxytryptamine 1E antagonist | 0.169 0.167 DB03017 0.278 0.046 DB01238 0.238 0.088 DBMET00531 0.255 0.069 DBMET01611 | DB01238 | |
| 0.022 | 0.354 | 0.067 | Vanilloid 2 antagonist | 0.067 0.016 DB03017 | DB03017 | |
| 0.026 | 0.359 | 0.309 | Prolactin inhibitor | 0.309 0.003 DB03017 0.145 0.024 DBMET00531 | DB03017 | |
| 0.007 | 0.34 | 0.118 | NMDA 2C receptor antagonist | 0.118 0.011 DB03017 0.099 0.016 DB01238 0.064 0.039 DBMET01611 | DB03017 | |
| 0.029 | 0.364 | 0.324 | Protein-tyrosine phosphatase inhibitor | 0.324 0.015 DB03017 | DB03017 | |
| 0.022 | 0.357 | 0.087 | Corticotropin releasing factor 2 receptor antagonist | 0.087 0.012 DB03017 0.067 0.032 DBMET00531 | DB03017 | |
| 0.041 | 0.378 | 0.13 | Glutamate (mGluR7) agonist | 0.13 0.022 DB03017 0.121 0.03 DBMET00531 | DB03017 | |
| 0.036 | 0.375 | 0.068 | Calcium channel P-type blocker | 0.067 0.035 DB03017 0.068 0.033 DBMET00531 | DBMET00531 | |
| 0.014 | 0.354 | 0.097 | Androgen antagonist | 0.097 0.049 DB03017 | DB03017 | |
| 0.063 | 0.403 | 0.311 | Neurotrophic factor enhancer | 0.311 0.015 DB03017 0.216 0.062 DBMET00531 | DB03017 | |
| 0.004 | 0.345 | 0.053 | Retinoid X beta receptor agonist | 0.053 0.005 DB03017 | DB03017 | |
| 0.001 | 0.344 | 0.012 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.012 0.003 DB03017 | DB03017 | |
| 0.013 | 0.358 | 0.081 | Acetylcholine nicotinic antagonist | 0.081 0.053 DB03017 | DB03017 | |
| 0.04 | 0.39 | 0.269 | Arachidonic acid antagonist | 0.269 0.003 DB03017 0.212 0.023 DBMET00531 | DB03017 | |
| 0.017 | 0.367 | 0.209 | 5-Lipoxygenase inhibitor | 0.209 0.023 DB03017 | DB03017 | |
| 0.003 | 0.353 | 0.035 | Prostaglandin EP1 antagonist | 0.035 0.009 DB03017 | DB03017 | |
| 0.008 | 0.358 | 0.056 | Integrin alpha5beta1 antagonist | 0.056 0.014 DB03017 | DB03017 | |
| 0.038 | 0.39 | 0.403 | Photosensitizer | 0.403 0.003 DB03017 0.141 0.037 DBMET00531 | DB03017 | |
| 0.004 | 0.356 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.024 DB03017 | DB03017 | |
| 0.008 | 0.361 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 DB03017 | DB03017 | |
| 0.003 | 0.359 | 0.062 | Uridine phosphorylase inhibitor | 0.062 0.005 DB03017 0.043 0.01 DBMET00531 | DB03017 | |
| 0.05 | 0.406 | 0.244 | Antipruritic | 0.244 0.026 DB03017 | DB03017 | |
| 0.031 | 0.389 | 0.313 | Electrolyte absorption antagonist | 0.313 0.004 DB03017 0.156 0.017 DBMET00531 | DB03017 | |
| 0.048 | 0.407 | 0.293 | DNA methylase inhibitor | 0.293 0.03 DB03017 0.175 0.097 DBMET01611 | DB03017 | |
| 0.004 | 0.364 | 0.055 | Angiotensin AT2 receptor antagonist | 0.055 0.009 DB03017 | DB03017 | |
| 0.034 | 0.396 | 0.112 | MDM2 inhibitor | 0.112 0.005 DB03017 0.07 0.039 DB01238 0.069 0.041 DBMET00531 0.073 0.03 DBMET01611 | DB03017 | |
| 0.038 | 0.4 | 0.111 | Phosphodiesterase 6D inhibitor | 0.111 0.035 DB03017 0.1 0.051 DB01238 0.089 0.077 DBMET00531 0.088 0.082 DBMET01611 | DB03017 | |
| 0.053 | 0.415 | 0.309 | Hepatoprotectant | 0.309 0.027 DB03017 | DB03017 | |
| 0.01 | 0.374 | 0.053 | Benzodiazepine antagonist | 0.053 0.022 DB03017 | DB03017 | |
| 0.012 | 0.376 | 0.085 | MAO A inhibitor | 0.085 0.075 DB01238 | DB01238 | |
| 0.025 | 0.39 | 0.262 | Glycine receptor agonist | 0.262 0.003 DB03017 0.114 0.014 DBMET00531 | DB03017 | |
| 0.036 | 0.4 | 0.2 | Vanilloid agonist | 0.2 0.007 DB03017 | DB03017 | |
| 0.053 | 0.419 | 0.273 | Adenylate cyclase stimulant | 0.273 0.003 DB03017 0.185 0.022 DBMET00531 | DB03017 | |
| 0.021 | 0.388 | 0.117 | Caspase 7 inhibitor | 0.117 0.016 DB03017 0.076 0.071 DBMET00531 | DB03017 | |
| 0.018 | 0.386 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.046 DB03017 | DB03017 | |
| 0.014 | 0.383 | 0.127 | Sphingosine 1-phosphate receptor 3 antagonist | 0.127 0.005 DB03017 | DB03017 | |
| 0.008 | 0.377 | 0.051 | GABA receptor antagonist | 0.051 0.042 DB03017 | DB03017 | |
| 0.034 | 0.404 | 0.295 | Dual specificity phosphatase 3 inhibitor | 0.295 0.03 DB03017 | DB03017 | |
| 0.008 | 0.379 | 0.062 | Dihydrofolate reductase inhibitor | 0.062 0.009 DB03017 | DB03017 | |
| 0.005 | 0.376 | 0.034 | Integrin beta5 antagonist | 0.034 0.007 DB03017 | DB03017 | |
| 0.015 | 0.386 | 0.133 | MAO inhibitor | 0.133 0.068 DB01238 | DB01238 | |
| 0.004 | 0.376 | 0.062 | Melanin-concentrating hormone receptor 1 antagonist | 0.062 0.029 DB01238 0.053 0.037 DBMET01611 | DB01238 | |
| 0.012 | 0.385 | 0.15 | CDC25B inhibitor | 0.15 0.006 DB03017 | DB03017 | |
| 0.005 | 0.377 | 0.186 | NMDA 2 receptor antagonist | 0.064 0.058 DB03017 0.186 0.011 DB01238 0.153 0.016 DBMET01611 | DB01238 | |
| 0.015 | 0.388 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DB03017 | DB03017 | |
| 0.002 | 0.376 | 0.062 | Thromboxane A2 agonist | 0.062 0.002 DB03017 0.019 0.007 DBMET00531 | DB03017 | |
| 0.019 | 0.392 | 0.155 | Glutamate receptor antagonist | 0.155 0.048 DB01238 0.147 0.053 DBMET01611 | DB01238 | |
| 0.017 | 0.391 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.021 DB03017 0.066 0.031 DBMET00531 | DB03017 | |
| 0.045 | 0.42 | 0.236 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.193 0.082 DB01238 0.236 0.056 DBMET01611 | DBMET01611 | |
| 0.006 | 0.381 | 0.047 | Collagenase inhibitor | 0.047 0.039 DB03017 | DB03017 | |
| 0.016 | 0.393 | 0.1 | Protein kinase C zeta inhibitor | 0.09 0.064 DB01238 0.1 0.05 DBMET01611 | DBMET01611 | |
| 0.002 | 0.38 | 0.039 | Neutral endopeptidase inhibitor | 0.039 0.009 DB03017 | DB03017 | |
| 0.094 | 0.471 | 0.163 | MAP kinase kinase 5 inhibitor | 0.163 0.106 DB01238 0.162 0.109 DBMET01611 | DB01238 | |
| 0.004 | 0.382 | 0.16 | Antimetabolite | 0.16 0.011 DB03017 | DB03017 | |
| 0.015 | 0.393 | 0.049 | Human rhinovirus A protease inhibitor | 0.049 0.044 DB03017 | DB03017 | |
| 0.008 | 0.387 | 0.054 | Nerve growth factor antagonist | 0.046 0.024 DB03017 0.054 0.014 DBMET00531 | DBMET00531 | |
| 0.012 | 0.391 | 0.065 | VCAM-1 antagonist | 0.065 0.005 DB03017 | DB03017 | |
| 0.005 | 0.385 | 0.022 | Integrin beta6 antagonist | 0.022 0.004 DB03017 | DB03017 | |
| 0.012 | 0.392 | 0.065 | VCAM antagonist | 0.065 0.005 DB03017 | DB03017 | |
| 0.042 | 0.423 | 0.08 | T cell inhibitor | 0.08 0.064 DB03017 | DB03017 | |
| 0.006 | 0.388 | 0.037 | Nicotinic acid receptor 2 agonist | 0.037 0.023 DB03017 | DB03017 | |
| 0.004 | 0.386 | 0.067 | Retinoid X gamma receptor agonist | 0.067 0.004 DB03017 | DB03017 | |
| 0.014 | 0.397 | 0.05 | Neurotensin receptor antagonist | 0.05 0.028 DB03017 | DB03017 | |
| 0.003 | 0.386 | 0.067 | Integrin beta3 antagonist | 0.067 0.005 DB03017 | DB03017 | |
| 0.025 | 0.408 | 0.221 | Chelator | 0.221 0.021 DB03017 | DB03017 | |
| 0.014 | 0.398 | 0.059 | Vanilloid 3 antagonist | 0.059 0.005 DB03017 0.042 0.018 DBMET00531 | DB03017 | |
| 0.002 | 0.386 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.005 DB03017 | DB03017 | |
| 0.005 | 0.39 | 0.127 | NMDA receptor subunit 3B antagonist | 0.127 0.008 DB03017 | DB03017 | |
| 0.003 | 0.389 | 0.075 | VLA-4 antagonist | 0.075 0.008 DB03017 | DB03017 | |
| 0.005 | 0.391 | 0.064 | Integrin alphaVbeta3 antagonist | 0.064 0.004 DB03017 | DB03017 | |
| 0.004 | 0.39 | 0.019 | Retinoic acid receptor antagonist | 0.019 0.012 DB03017 | DB03017 | |
| 0.04 | 0.428 | 0.137 | Estrogen-related receptor beta agonist | 0.137 0.005 DB03017 0.108 0.017 DBMET00531 | DB03017 | |
| 0.004 | 0.392 | 0.083 | Free fatty acid receptor 1 antagonist | 0.083 0.004 DB03017 0.031 0.027 DBMET00531 | DB03017 | |
| 0.01 | 0.399 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.057 DB03017 0.076 0.054 DBMET00531 0.089 0.041 DBMET01611 | DBMET01611 | |
| 0.031 | 0.423 | 0.245 | Anticoagulant | 0.245 0.04 DB03017 | DB03017 | |
| 0.006 | 0.398 | 0.091 | NMDA 2A receptor antagonist | 0.091 0.016 DB03017 | DB03017 | |
| 0.005 | 0.4 | 0.099 | MAO B inhibitor | 0.099 0.06 DB01238 | DB01238 | |
| 0.009 | 0.405 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.026 DB03017 0.046 0.043 DBMET00531 | DB03017 | |
| 0.074 | 0.474 | 0.662 | 5 Hydroxytryptamine release stimulant | 0.662 0.009 DB03017 0.49 0.029 DBMET00531 | DB03017 | |
| 0.015 | 0.415 | 0.049 | Guanylate cyclase stimulant | 0.049 0.021 DB03017 | DB03017 | |
| 0.008 | 0.408 | 0.097 | Neuraminidase inhibitor | 0.097 0.017 DB03017 | DB03017 | |
| 0.017 | 0.421 | 0.067 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DB03017 0.067 0.025 DBMET01611 | DBMET01611 | |
| 0.023 | 0.427 | 0.17 | Histone deacetylase class III inhibitor | 0.17 0.031 DB03017 | DB03017 | |
| 0.011 | 0.417 | 0.065 | Beta 2 adrenoreceptor antagonist | 0.065 0.02 DB03017 | DB03017 | |
| 0.018 | 0.424 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.028 DB03017 0.056 0.032 DBMET00531 | DB03017 | |
| 0.011 | 0.417 | 0.096 | Neuraminidase (influenza) inhibitor | 0.096 0.017 DB03017 | DB03017 | |
| 0.009 | 0.416 | 0.082 | Androgen agonist | 0.082 0.023 DB03017 0.058 0.044 DBMET00531 | DB03017 | |
| 0.031 | 0.44 | 0.333 | Dual specificity phosphatase inhibitor | 0.333 0.023 DB03017 | DB03017 | |
| 0.043 | 0.453 | 0.885 | Succinate dehydrogenase inhibitor | 0.885 0.002 DB03017 0.303 0.01 DBMET00531 | DB03017 | |
| 0.037 | 0.448 | 0.294 | Free radical scavenger | 0.294 0.053 DB03017 | DB03017 | |
| 0.005 | 0.416 | 0.056 | Liver X receptor beta antagonist | 0.056 0.007 DB03017 | DB03017 | |
| 0.023 | 0.436 | 0.31 | Diuretic | 0.31 0.021 DB03017 | DB03017 | |
| 0.003 | 0.416 | 0.021 | Retinoic acid alpha receptor antagonist | 0.021 0.013 DB03017 | DB03017 | |
| 0.003 | 0.417 | 0.057 | G protein-coupled receptor agonist | 0.057 0.014 DB03017 | DB03017 | |
| 0.006 | 0.419 | 0.06 | Thyroid hormone agonist | 0.06 0.004 DB03017 | DB03017 | |
| 0.005 | 0.419 | 0.073 | Caspase 2 inhibitor | 0.073 0.007 DB03017 | DB03017 | |
| 0.024 | 0.438 | 0.141 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.134 0.101 DB01238 0.141 0.095 DBMET01611 | DBMET01611 | |
| 0.018 | 0.433 | 0.13 | Potassium channel (Ca-activated) activator | 0.13 0.036 DB03017 | DB03017 | |
| 0.014 | 0.428 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 DB03017 0.044 0.038 DBMET01611 | DB03017 | |
| 0.049 | 0.463 | 0.281 | Calpain 2 inhibitor | 0.281 0.127 DB03017 | DB03017 | |
| 0.023 | 0.438 | 0.1 | Chymotrypsin inhibitor | 0.1 0.036 DB03017 | DB03017 | |
| 0.003 | 0.418 | 0.032 | Vitamin D receptor agonist | 0.032 0.004 DB03017 | DB03017 | |
| 0.006 | 0.423 | 0.09 | Nicotinic acid receptor agonist | 0.09 0.005 DB03017 | DB03017 | |
| 0.005 | 0.423 | 0.263 | Integrin antagonist | 0.263 0.005 DB03017 | DB03017 | |
| 0.003 | 0.423 | 0.105 | Integrin alpha4 antagonist | 0.105 0.005 DB03017 | DB03017 | |
| 0.019 | 0.441 | 0.051 | Sodium/calcium exchanger inhibitor | 0.051 0.032 DBMET01611 | DBMET01611 | |
| 0.067 | 0.49 | 0.268 | Neurotensin receptor agonist | 0.268 0.018 DB03017 0.167 0.067 DBMET00531 | DB03017 | |
| 0.003 | 0.426 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.024 DB03017 | DB03017 | |
| 0.01 | 0.433 | 0.108 | Epoxide hydrolase inhibitor | 0.108 0.021 DB03017 | DB03017 | |
| 0.072 | 0.496 | 0.45 | Sodium/bile acid cotransporter inhibitor | 0.45 0.007 DB03017 | DB03017 | |
| 0.004 | 0.429 | 0.076 | 5 Hydroxytryptamine 2 agonist | 0.076 0.017 DB01238 0.049 0.039 DBMET01611 | DB01238 | |
| 0.005 | 0.43 | 0.044 | Integrin alphaVbeta1 antagonist | 0.044 0.005 DB03017 | DB03017 | |
| 0.044 | 0.47 | 0.359 | Lipoxygenase inhibitor | 0.359 0.048 DB03017 | DB03017 | |
| 0.01 | 0.438 | 0.058 | Cannabinoid CB1 receptor antagonist | 0.058 0.047 DBMET01611 | DBMET01611 | |
| 0.024 | 0.454 | 0.333 | Glutamate (mGluR6) antagonist | 0.333 0.002 DB03017 0.107 0.008 DBMET00531 | DB03017 | |
| 0.001 | 0.431 | 0.082 | Lysophosphatidic acid receptor 3 agonist | 0.082 0.002 DB03017 0.02 0.005 DBMET00531 | DB03017 | |
| 0.002 | 0.433 | 0.053 | Prostaglandin H2 antagonist | 0.053 0.003 DB03017 | DB03017 | |
| 0.005 | 0.438 | 0.038 | Cholesterol ester transfer protein antagonist | 0.038 0.014 DB03017 | DB03017 | |
| 0.009 | 0.443 | 0.104 | Maillard reaction inhibitor | 0.104 0.015 DB03017 | DB03017 | |
| 0.016 | 0.455 | 0.144 | Falcipain 3 inhibitor | 0.144 0.039 DB03017 0.126 0.05 DBMET00531 | DB03017 | |
| 0.053 | 0.495 | 0.55 | Superoxide dismutase inhibitor | 0.55 0.009 DB03017 0.342 0.038 DBMET00531 0.18 0.141 DBMET01611 | DB03017 | |
| 0.05 | 0.493 | 0.262 | Vanilloid 1 agonist | 0.262 0.005 DB03017 0.129 0.068 DBMET00531 | DB03017 | |
| 0.012 | 0.456 | 0.069 | Cytokine production stimulant | 0.069 0.008 DB03017 0.051 0.027 DBMET00531 | DB03017 | |
| 0.021 | 0.466 | 0.182 | Anabolic | 0.182 0.007 DB03017 0.141 0.023 DBMET00531 | DB03017 | |
| 0.009 | 0.456 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 DB03017 | DB03017 | |
| 0.008 | 0.455 | 0.041 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 DB01238 | DB01238 | |
| 0.014 | 0.462 | 0.079 | Hepatocyte growth factor antagonist | 0.079 0.076 DBMET01611 | DBMET01611 | |
| 0.009 | 0.457 | 0.254 | Protein-tyrosine phosphatase 1B inhibitor | 0.254 0.016 DB03017 | DB03017 | |
| 0.014 | 0.463 | 0.117 | Glutamate (mGluR group III) antagonist | 0.117 0.005 DB03017 0.044 0.03 DBMET00531 | DB03017 | |
| 0.004 | 0.455 | 0.096 | NMDA receptor subunit 3A antagonist | 0.096 0.009 DB03017 | DB03017 | |
| 0.034 | 0.487 | 0.718 | Aldehyde oxidase inhibitor | 0.718 0.007 DB03017 0.535 0.028 DBMET00531 | DB03017 | |
| 0.003 | 0.459 | 0.037 | Isoleucine-tRNA ligase inhibitor | 0.037 0.004 DB03017 0.024 0.013 DBMET00531 | DB03017 | |
| 0.003 | 0.461 | 0.111 | Retinoid X receptor agonist | 0.111 0.004 DB03017 | DB03017 | |
| 0.006 | 0.465 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 DB03017 | DB03017 | |
| 0.006 | 0.467 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DB03017 | DB03017 | |
| 0.004 | 0.467 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DB03017 0.028 0.012 DBMET00531 | DB03017 | |
| 0.034 | 0.499 | 0.393 | Non-steroidal antiinflammatory agent | 0.393 0.014 DB03017 | DB03017 | |
| 0.046 | 0.512 | 0.402 | Transcription factor NF kappa B inhibitor | 0.402 0.063 DB03017 | DB03017 | |
| 0.058 | 0.525 | 0.487 | Toll-Like receptor agonist | 0.487 0.034 DB03017 | DB03017 | |
| 0.033 | 0.501 | 0.152 | Transcription factor NF kappa B stimulant | 0.152 0.015 DB03017 | DB03017 | |
| 0.021 | 0.489 | 0.148 | Nav1.6 sodium channel blocker | 0.148 0.057 DB03017 0.124 0.089 DBMET00531 | DB03017 | |
| 0.022 | 0.493 | 0.06 | Cathepsin E inhibitor | 0.06 0.04 DB03017 | DB03017 | |
| 0.037 | 0.509 | 0.255 | GABA C receptor rho-2 antagonist | 0.255 0.011 DB03017 0.253 0.011 DBMET00531 0.124 0.117 DBMET01611 | DB03017 | |
| 0.017 | 0.489 | 0.199 | Toll-Like receptor 9 antagonist | 0.199 0.036 DBMET01611 | DBMET01611 | |
| 0.061 | 0.535 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.369 0.022 DB03017 0.268 0.041 DBMET00531 | DB03017 | |
| 0.014 | 0.491 | 0.24 | Cathepsin G inhibitor | 0.24 0.013 DB03017 | DB03017 | |
| 0.005 | 0.487 | 0.119 | Macrophage elastase inhibitor | 0.119 0.007 DB03017 | DB03017 | |
| 0.07 | 0.552 | 0.271 | Caspase 3 stimulant | 0.271 0.095 DB03017 | DB03017 | |
| 0.006 | 0.493 | 0.03 | NMDA 2D receptor antagonist | 0.03 0.016 DB03017 | DB03017 | |
| 0.046 | 0.539 | 0.122 | Factor V inhibitor | 0.122 0.037 DB03017 | DB03017 | |
| 0.009 | 0.503 | 0.084 | Sphingosine kinase 2 inhibitor | 0.084 0.013 DB03017 0.058 0.034 DBMET00531 | DB03017 | |
| 0.004 | 0.499 | 0.048 | Potassium channel Kv1.3 blocker | 0.048 0.032 DB03017 | DB03017 | |
| 0.004 | 0.5 | 0.064 | Angiotensin AT1 receptor antagonist | 0.064 0.005 DB03017 | DB03017 | |
| 0.029 | 0.525 | 0.135 | NADPH oxidase inhibitor | 0.135 0.066 DB03017 | DB03017 | |
| 0.005 | 0.503 | 0.101 | Lysophosphatidic acid receptor 1 agonist | 0.101 0.002 DB03017 0.032 0.009 DBMET00531 | DB03017 | |
| 0.005 | 0.503 | 0.072 | Metalloproteinase-3 inhibitor | 0.072 0.018 DB03017 | DB03017 | |
| 0.013 | 0.511 | 0.098 | Pregnane X receptor antagonist | 0.098 0.004 DB03017 0.073 0.011 DBMET00531 | DB03017 | |
| 0.017 | 0.516 | 0.075 | Bombesin 2 receptor antagonist | 0.075 0.018 DB03017 | DB03017 | |
| 0.001 | 0.501 | 0.04 | Carbonic anhydrase XI inhibitor | 0.04 0.002 DB03017 0.016 0.005 DBMET00531 | DB03017 | |
| 0.001 | 0.503 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.009 DB03017 0.047 0.01 DBMET00531 | DB03017 | |
| 0.005 | 0.506 | 0.038 | RNA-directed RNA polymerase inhibitor | 0.038 0.02 DB03017 | DB03017 | |
| 0.053 | 0.555 | 0.423 | Toll-Like receptor 7 agonist | 0.423 0.051 DB03017 | DB03017 | |
| 0.026 | 0.529 | 0.246 | TRPA1 agonist | 0.246 0.005 DB03017 0.117 0.062 DBMET00531 | DB03017 | |
| 0.001 | 0.504 | 0.112 | Arginase inhibitor | 0.112 0.003 DB03017 0.045 0.018 DBMET00531 | DB03017 | |
| 0.006 | 0.513 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.042 DB03017 | DB03017 | |
| 0.015 | 0.523 | 0.108 | Protease inhibitor | 0.108 0.058 DB03017 | DB03017 | |
| 0.007 | 0.518 | 0.101 | Sphingosine kinase inhibitor | 0.101 0.007 DB03017 | DB03017 | |
| 0.003 | 0.514 | 0.084 | Phosphoglycerate kinase inhibitor | 0.084 0.008 DB03017 0.037 0.022 DBMET00531 | DB03017 | |
| 0.005 | 0.518 | 0.063 | Angiotensin II receptor antagonist | 0.063 0.004 DB03017 | DB03017 | |
| 0.003 | 0.516 | 0.054 | Retinoid X beta receptor antagonist | 0.054 0.002 DB03017 0.022 0.011 DBMET00531 | DB03017 | |
| 0.014 | 0.529 | 0.082 | Glucosylceramidase inhibitor | 0.082 0.014 DB03017 | DB03017 | |
| 0.005 | 0.522 | 0.047 | Histamine agonist | 0.047 0.045 DBMET01611 | DBMET01611 | |
| 0.027 | 0.545 | 0.214 | Antiamyloidogenic | 0.214 0.091 DB03017 | DB03017 | |
| 0.016 | 0.534 | 0.187 | Interleukin 1 beta converting enzyme inhibitor | 0.187 0.008 DB03017 | DB03017 | |
| 0.002 | 0.523 | 0.069 | Kynurenine 3 monooxygenase inhibitor | 0.069 0.005 DB03017 | DB03017 | |
| 0.017 | 0.539 | 0.202 | Glutathione S-transferase inhibitor | 0.202 0.005 DB03017 0.078 0.065 DBMET00531 | DB03017 | |
| 0.019 | 0.542 | 0.068 | Phosphodiesterase VI inhibitor | 0.068 0.067 DBMET01611 | DBMET01611 | |
| 0.012 | 0.535 | 0.196 | Glycine receptor antagonist | 0.196 0.004 DB03017 0.118 0.019 DBMET00531 | DB03017 | |
| 0.001 | 0.525 | 0.087 | Kainate receptor 1 antagonist | 0.087 0.004 DB03017 | DB03017 | |
| 0.024 | 0.55 | 0.242 | Calpain inhibitor | 0.242 0.073 DB03017 | DB03017 | |
| 0.004 | 0.53 | 0.034 | LFA antagonist | 0.034 0.011 DB03017 | DB03017 | |
| 0.024 | 0.55 | 0.296 | Amylase inhibitor | 0.296 0.019 DB03017 0.16 0.059 DBMET00531 | DB03017 | |
| 0.016 | 0.542 | 0.215 | Caspase 3 inhibitor | 0.215 0.007 DB03017 | DB03017 | |
| 0.004 | 0.53 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DB03017 0.023 0.01 DBMET00531 | DBMET00531 | |
| 0.045 | 0.574 | 0.4 | Antibacterial | 0.4 0.077 DB03017 | DB03017 | |
| 0.044 | 0.573 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.131 DB01238 | DB01238 | |
| 0.011 | 0.541 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.09 0.02 DB03017 0.074 0.033 DBMET00531 | DB03017 | |
| 0.016 | 0.548 | 0.125 | CD45 antagonist | 0.125 0.007 DB03017 | DB03017 | |
| 0.012 | 0.546 | 0.25 | Mucolytic | 0.25 0.006 DB03017 0.132 0.045 DBMET00531 | DB03017 | |
| 0.002 | 0.536 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DB03017 | DB03017 | |
| 0.004 | 0.539 | 0.071 | Dopamine D5 agonist | 0.069 0.009 DB03017 0.071 0.008 DBMET00531 | DBMET00531 | |
| 0.019 | 0.556 | 0.253 | Xanthine oxidase inhibitor | 0.16 0.031 DB03017 0.253 0.012 DBMET00531 | DBMET00531 | |
| 0.012 | 0.55 | 0.126 | Glutamate (mGluR4) antagonist | 0.126 0.004 DB03017 0.046 0.025 DBMET00531 | DB03017 | |
| 0.09 | 0.628 | 0.262 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.129 DB03017 0.19 0.082 DB01238 0.262 0.012 DBMET00531 0.2 0.062 DBMET01611 | DBMET00531 | |
| 0.009 | 0.55 | 0.077 | Retinoid X receptor antagonist | 0.077 0.003 DB03017 0.039 0.025 DBMET00531 | DB03017 | |
| 0.003 | 0.545 | 0.06 | Epoxide hydrolase 1 inhibitor | 0.06 0.004 DB03017 0.033 0.018 DBMET00531 | DB03017 | |
| 0.003 | 0.545 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 DB03017 | DB03017 | |
| 0.036 | 0.579 | 0.203 | Hypoxia-inducible factor 1 alpha inhibitor | 0.203 0.148 DB03017 | DB03017 | |
| 0.005 | 0.552 | 0.091 | Glutamate receptor agonist | 0.091 0.044 DB03017 | DB03017 | |
| 0.004 | 0.552 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 DB03017 | DB03017 | |
| 0.103 | 0.651 | 0.514 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.399 0.102 DB03017 0.327 0.178 DB01238 0.514 0.028 DBMET00531 0.307 0.203 DBMET01611 | DBMET00531 | |
| 0.014 | 0.562 | 0.185 | Microtubule formation inhibitor | 0.185 0.024 DB03017 0.127 0.053 DBMET00531 | DB03017 | |
| 0.012 | 0.562 | 0.187 | Carbonic anhydrase XIII inhibitor | 0.187 0.016 DB03017 0.07 0.058 DBMET00531 | DB03017 | |
| 0.014 | 0.564 | 0.095 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.051 DB03017 | DB03017 | |
| 0.005 | 0.555 | 0.078 | Matrix metalloproteinase (membrane-type) inhibitor | 0.078 0.021 DB03017 | DB03017 | |
| 0.01 | 0.563 | 0.054 | Phosphodiesterase 7A inhibitor | 0.054 0.031 DBMET01611 | DBMET01611 | |
| 0.007 | 0.561 | 0.12 | Metalloproteinase-2 inhibitor | 0.12 0.029 DB03017 | DB03017 | |
| 0.022 | 0.576 | 0.275 | Cell wall synthesis inhibitor | 0.275 0.012 DB03017 0.139 0.076 DBMET00531 | DB03017 | |
| 0.006 | 0.56 | 0.092 | Metalloproteinase-9 inhibitor | 0.092 0.037 DB03017 | DB03017 | |
| 0.016 | 0.572 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.052 DB03017 | DB03017 | |
| 0.005 | 0.562 | 0.088 | Matrix metalloproteinase inhibitor | 0.088 0.032 DB03017 | DB03017 | |
| 0.021 | 0.579 | 0.141 | Vanilloid 4 agonist | 0.141 0.004 DB03017 0.101 0.016 DBMET00531 | DB03017 | |
| 0.008 | 0.567 | 0.064 | Retinoid X alpha receptor antagonist | 0.064 0.003 DB03017 0.035 0.023 DBMET00531 | DB03017 | |
| 0.005 | 0.566 | 0.061 | Sphingosine kinase 1 inhibitor | 0.061 0.009 DB03017 | DB03017 | |
| 0.001 | 0.565 | 0.089 | AMPA 1 receptor antagonist | 0.089 0.006 DB03017 | DB03017 | |
| 0.008 | 0.571 | 0.078 | Adenylate cyclase 1 inhibitor | 0.056 0.021 DB03017 0.078 0.009 DBMET00531 | DBMET00531 | |
| 0.001 | 0.564 | 0.11 | Carbonic anhydrase VIII inhibitor | 0.11 0.001 DB03017 0.033 0.004 DBMET00531 | DB03017 | |
| 0.001 | 0.564 | 0.11 | Carbonic anhydrase X inhibitor | 0.11 0.001 DB03017 0.033 0.004 DBMET00531 | DB03017 | |
| 0.012 | 0.576 | 0.273 | Cystathionine beta-synthase inhibitor | 0.273 0.012 DB03017 0.208 0.023 DBMET00531 | DB03017 | |
| 0.066 | 0.632 | 0.579 | Tyrosine 3 hydroxylase inhibitor | 0.579 0.003 DB03017 0.372 0.012 DBMET00531 | DB03017 | |
| 0.001 | 0.567 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DB03017 | DB03017 | |
| 0.006 | 0.574 | 0.168 | AMPA 4 receptor antagonist | 0.168 0.004 DB03017 | DB03017 | |
| 0.003 | 0.576 | 0.044 | Matrix metalloproteinase 1 inhibitor | 0.044 0.043 DB03017 | DB03017 | |
| 0.001 | 0.574 | 0.019 | Integrin alpha4beta1 antagonist | 0.019 0.01 DB03017 | DB03017 | |
| 0.003 | 0.577 | 0.092 | Geranyltranstransferase inhibitor | 0.092 0.004 DB03017 0.055 0.018 DBMET00531 | DB03017 | |
| 0.003 | 0.577 | 0.093 | AMPA 3 receptor antagonist | 0.093 0.004 DB03017 | DB03017 | |
| 0.006 | 0.582 | 0.057 | Endothelin-converting enzyme inhibitor | 0.057 0.026 DB03017 | DB03017 | |
| 0.008 | 0.585 | 0.277 | Expectorant | 0.277 0.01 DB03017 0.103 0.065 DBMET00531 | DB03017 | |
| 0.008 | 0.586 | 0.056 | Epithelial sodium channel blocker | 0.056 0.035 DB03017 0.056 0.035 DBMET00531 | DBMET00531 | |
| 0.005 | 0.585 | 0.037 | Histone deacetylase 9 inhibitor | 0.037 0.032 DB03017 | DB03017 | |
| 0.001 | 0.582 | 0.027 | Angiotensin AT1B receptor antagonist | 0.027 0.004 DB03017 | DB03017 | |
| 0.023 | 0.606 | 0.166 | Pregnane X receptor agonist | 0.166 0.03 DB03017 0.142 0.069 DBMET00531 | DB03017 | |
| 0.014 | 0.598 | 0.151 | AMP-activated protein kinase stimulant | 0.151 0.028 DB03017 | DB03017 | |
| 0.002 | 0.59 | 0.045 | Methionyl aminopeptidase 1 inhibitor | 0.045 0.008 DB03017 | DB03017 | |
| 0.005 | 0.594 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.092 0.013 DB03017 | DB03017 | |
| 0.005 | 0.597 | 0.057 | Phosphodiesterase VII inhibitor | 0.057 0.05 DBMET01611 | DBMET01611 | |
| 0.019 | 0.612 | 0.279 | Carbonic anhydrase III inhibitor | 0.279 0.007 DB03017 0.115 0.048 DBMET00531 | DB03017 | |
| 0.005 | 0.599 | 0.166 | Mannosidase inhibitor | 0.166 0.004 DB03017 0.066 0.014 DBMET00531 | DB03017 | |
| 0.006 | 0.6 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.023 DB03017 0.033 0.024 DBMET00531 | DBMET00531 | |
| 0.013 | 0.607 | 0.215 | GABA B receptor agonist | 0.215 0.003 DB03017 0.094 0.022 DBMET00531 | DB03017 | |
| 0.006 | 0.603 | 0.141 | Membrane dipeptidase inhibitor | 0.141 0.002 DB03017 0.051 0.015 DBMET00531 | DB03017 | |
| 0.013 | 0.612 | 0.187 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 DB01238 0.187 0.019 DBMET00531 0.133 0.046 DBMET01611 | DBMET00531 | |
| 0.004 | 0.603 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.041 0.012 DB03017 | DB03017 | |
| 0.014 | 0.614 | 0.098 | Insulin receptor antagonist | 0.098 0.064 DB01238 | DB01238 | |
| 0.009 | 0.61 | 0.075 | Cyclin D1 inhibitor | 0.055 0.051 DBMET00531 0.075 0.023 DBMET01611 | DBMET01611 | |
| 0.005 | 0.606 | 0.034 | Caspase 8 inhibitor | 0.034 0.004 DB03017 | DB03017 | |
| 0.076 | 0.678 | 0.607 | 5 Hydroxytryptamine uptake stimulant | 0.607 0.003 DB03017 0.402 0.014 DBMET00531 | DB03017 | |
| 0.005 | 0.612 | 0.075 | Collagenase 3 inhibitor | 0.075 0.028 DB03017 | DB03017 | |
| 0.007 | 0.614 | 0.029 | Glucosylceramidase stimulant | 0.029 0.015 DB03017 0.028 0.017 DBMET00531 | DB03017 | |
| 0.003 | 0.614 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 DB03017 | DB03017 | |
| 0.002 | 0.614 | 0.125 | Kainate receptor antagonist | 0.125 0.005 DB03017 | DB03017 | |
| 0.01 | 0.623 | 0.04 | Aggrecanase 1 inhibitor | 0.04 0.027 DB03017 | DB03017 | |
| 0.005 | 0.618 | 0.454 | Carbamoyl phosphate synthetase inhibitor | 0.454 0.003 DB03017 0.196 0.008 DBMET00531 | DB03017 | |
| 0.014 | 0.627 | 0.288 | GABA C receptor rho-1 antagonist | 0.288 0.004 DB03017 0.205 0.007 DBMET00531 | DB03017 | |
| 0.009 | 0.624 | 0.242 | Glucose-6-phosphate isomerase inhibitor | 0.242 0.001 DB03017 0.111 0.004 DBMET00531 | DB03017 | |
| 0.003 | 0.618 | 0.122 | Retinoid X alpha receptor agonist | 0.122 0.004 DB03017 0.034 0.025 DBMET00531 | DB03017 | |
| 0.018 | 0.634 | 0.457 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.457 0.003 DB03017 0.248 0.01 DBMET00531 | DB03017 | |
| 0.006 | 0.625 | 0.11 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.11 0.033 DB03017 0.078 0.053 DBMET00531 | DB03017 | |
| 0.004 | 0.626 | 0.075 | Peptide deformylase inhibitor | 0.075 0.005 DB03017 | DB03017 | |
| 0.008 | 0.632 | 0.128 | Kainate receptor agonist | 0.128 0.002 DB03017 0.062 0.006 DBMET00531 | DB03017 | |
| 0.001 | 0.626 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DB03017 0.018 0.005 DBMET00531 | DB03017 | |
| 0.008 | 0.634 | 0.126 | Glutamate (mGluR7) antagonist | 0.126 0.004 DB03017 0.104 0.009 DBMET00531 | DB03017 | |
| 0.003 | 0.63 | 0.027 | Integrin alpha4beta7 antagonist | 0.027 0.01 DB03017 | DB03017 | |
| 0.003 | 0.633 | 0.059 | Complement C3a chemotactic receptor antagonist | 0.059 0.022 DB03017 | DB03017 | |
| 0.016 | 0.645 | 0.26 | 12-Lipoxygenase inhibitor | 0.26 0.103 DB03017 | DB03017 | |
| 0.022 | 0.653 | 0.233 | Transcription factor STAT3 inhibitor | 0.233 0.098 DB03017 | DB03017 | |
| 0.006 | 0.636 | 0.142 | Alpha-mannosidase inhibitor | 0.142 0.004 DB03017 0.077 0.012 DBMET00531 | DB03017 | |
| 0.004 | 0.637 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.026 DB03017 | DB03017 | |
| 0.003 | 0.641 | 0.206 | Glutamate (mGluR3) antagonist | 0.206 0.003 DB03017 0.041 0.02 DBMET00531 | DB03017 | |
| 0.003 | 0.642 | 0.12 | Carbonic anhydrase VB inhibitor | 0.12 0.012 DB03017 0.062 0.033 DBMET00531 | DB03017 | |
| 0.002 | 0.643 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DB03017 0.017 0.008 DBMET00531 | DB03017 | |
| 0.004 | 0.645 | 0.093 | Neutrophil collagenase inhibitor | 0.093 0.025 DB03017 | DB03017 | |
| 0.003 | 0.645 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.012 DB03017 | DB03017 | |
| 0.07 | 0.712 | 0.259 | Peptidyltransferase inhibitor | 0.259 0.045 DB03017 | DB03017 | |
| 0.007 | 0.65 | 0.408 | Alcohol dehydrogenase inhibitor | 0.408 0.004 DB03017 0.096 0.057 DBMET00531 | DB03017 | |
| 0.002 | 0.646 | 0.02 | Integrin beta7 antagonist | 0.02 0.014 DB03017 | DB03017 | |
| 0.005 | 0.652 | 0.045 | Plasmepsin II inhibitor | 0.045 0.023 DB03017 | DB03017 | |
| 0.038 | 0.686 | 0.207 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.207 0.15 DBMET01611 | DBMET01611 | |
| 0.004 | 0.657 | 0.036 | Glutamate (mGluR1a) antagonist | 0.036 0.035 DB03017 | DB03017 | |
| 0.001 | 0.653 | 0.013 | Angiotensin AT2 receptor agonist | 0.013 0.005 DB03017 | DB03017 | |
| 0.004 | 0.659 | 0.249 | Monophenol monooxygenase inhibitor | 0.249 0.024 DB03017 | DB03017 | |
| 0.002 | 0.661 | 0.057 | AMPA receptor antagonist | 0.057 0.026 DB03017 | DB03017 | |
| 0.022 | 0.682 | 0.317 | 15-Lipoxygenase inhibitor | 0.317 0.12 DB03017 | DB03017 | |
| 0.002 | 0.664 | 0.108 | Glucagon receptor antagonist | 0.108 0.004 DB03017 | DB03017 | |
| 0.025 | 0.687 | 0.44 | Adenylate kinase inhibitor | 0.44 0.002 DB03017 0.257 0.009 DBMET00531 | DB03017 | |
| 0.003 | 0.667 | 0.137 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.137 0.009 DB03017 | DB03017 | |
| 0.003 | 0.668 | 0.071 | Lysophosphatidic acid 1 receptor antagonist | 0.071 0.003 DB03017 | DB03017 | |
| 0.005 | 0.673 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DB03017 | DB03017 | |
| 0.002 | 0.67 | 0.053 | Farnesoid X receptor agonist | 0.053 0.013 DB03017 | DB03017 | |
| 0.007 | 0.681 | 0.108 | Urease inhibitor | 0.108 0.058 DB03017 0.088 0.081 DBMET00531 | DB03017 | |
| 0.003 | 0.683 | 0.128 | NMDA receptor glycine site agonist | 0.128 0.007 DB03017 0.08 0.028 DBMET00531 | DB03017 | |
| 0.004 | 0.684 | 0.102 | GABA B receptor antagonist | 0.102 0.005 DB03017 | DB03017 | |
| 0.013 | 0.695 | 0.194 | Carbonic anhydrase VI inhibitor | 0.194 0.014 DB03017 0.084 0.052 DBMET00531 | DB03017 | |
| 0.016 | 0.698 | 0.074 | DNA helicase inhibitor | 0.074 0.014 DB03017 | DB03017 | |
| 0.001 | 0.685 | 0.012 | Integrin alphaVbeta5 antagonist | 0.012 0.006 DB03017 | DB03017 | |
| 0.009 | 0.694 | 0.251 | Ornithine decarboxylase inhibitor | 0.251 0.004 DB03017 0.096 0.048 DBMET00531 | DB03017 | |
| 0.014 | 0.699 | 0.177 | Focal adhesion kinase 2 inhibitor | 0.177 0.091 DB01238 | DB01238 | |
| 0.007 | 0.693 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.058 0.056 DB03017 0.06 0.048 DBMET00531 | DBMET00531 | |
| 0.02 | 0.709 | 0.214 | ATPase inhibitor | 0.214 0.027 DB03017 0.159 0.087 DBMET00531 0.18 0.058 DBMET01611 | DB03017 | |
| 0.058 | 0.748 | 0.187 | Heat shock protein 70 antagonist | 0.187 0.009 DB03017 0.149 0.049 DBMET00531 | DB03017 | |
| 0.009 | 0.699 | 0.069 | 5 Hydroxytryptamine 3 agonist | 0.069 0.037 DBMET00531 | DBMET00531 | |
| 0.021 | 0.711 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.113 0.018 DB03017 0.108 0.021 DBMET00531 | DB03017 | |
| 0.004 | 0.695 | 0.038 | Factor XIIIa inhibitor | 0.038 0.025 DB03017 | DB03017 | |
| 0.015 | 0.707 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | 0.136 0.009 DB03017 0.132 0.01 DBMET00531 | DB03017 | |
| 0.018 | 0.711 | 0.302 | Melanin inhibitor | 0.302 0.022 DB03017 0.154 0.076 DBMET00531 | DB03017 | |
| 0.001 | 0.694 | 0.063 | Ileal bile acid transport inhibitor | 0.063 0.003 DB03017 | DB03017 | |
| 0.003 | 0.702 | 0.258 | Acyl-CoA dehydrogenase inhibitor | 0.258 0.003 DB03017 0.181 0.006 DBMET00531 | DB03017 | |
| 0.007 | 0.707 | 0.042 | Hedgehog signaling activator | 0.042 0.004 DB03017 0.033 0.009 DBMET00531 | DB03017 | |
| 0.027 | 0.727 | 0.138 | DNA repair enzyme inhibitor | 0.138 0.044 DB03017 0.114 0.085 DBMET00531 0.116 0.08 DBMET01611 | DB03017 | |
| 0.003 | 0.705 | 0.029 | Thymidine phosphorylase inhibitor | 0.025 0.021 DB03017 0.029 0.014 DBMET00531 | DBMET00531 | |
| 0.002 | 0.708 | 0.072 | Dihydropteroate synthase inhibitor | 0.072 0.008 DB03017 0.043 0.023 DBMET00531 | DB03017 | |
| 0.009 | 0.721 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 DB03017 | DB03017 | |
| 0.02 | 0.735 | 0.219 | Transcription factor STAT inhibitor | 0.219 0.113 DB03017 | DB03017 | |
| 0.003 | 0.719 | 0.088 | Thymidylate synthase inhibitor | 0.088 0.005 DB03017 | DB03017 | |
| 0.027 | 0.744 | 0.384 | Insulysin inhibitor | 0.384 0.025 DB03017 0.274 0.076 DBMET00531 | DB03017 | |
| 0.004 | 0.722 | 0.124 | Carbonic anhydrase V inhibitor | 0.124 0.02 DB03017 0.06 0.054 DBMET00531 | DB03017 | |
| 0.012 | 0.731 | 0.154 | Proteasome inhibitor | 0.154 0.044 DB03017 | DB03017 | |
| 0.005 | 0.726 | 0.044 | MAP3K5 inhibitor | 0.044 0.019 DB03017 | DB03017 | |
| 0.006 | 0.727 | 0.078 | Heparanase inhibitor | 0.078 0.007 DB03017 0.05 0.045 DBMET00531 | DB03017 | |
| 0.006 | 0.728 | 0.062 | Glutamate (mGluR group III) agonist | 0.062 0.017 DB03017 | DB03017 | |
| 0 | 0.724 | 0.005 | Bone morphogenic protein 1 inhibitor | 0.005 0.004 DB03017 | DB03017 | |
| 0.004 | 0.732 | 0.478 | Aconitate hydratase inhibitor | 0.478 0.001 DB03017 0.144 0.004 DBMET00531 | DB03017 | |
| 0.003 | 0.731 | 0.067 | Xanthine dehydrogenase inhibitor | 0.067 0.034 DB03017 | DB03017 | |
| 0.008 | 0.737 | 0.373 | GABA C receptor antagonist | 0.373 0.004 DB03017 0.235 0.008 DBMET00531 | DB03017 | |
| 0.002 | 0.732 | 0.057 | Vanilloid 2 agonist | 0.057 0.002 DB03017 0.035 0.006 DBMET00531 | DB03017 | |
| 0.004 | 0.734 | 0.09 | Diacylglycerol O-acyltransferase inhibitor | 0.09 0.01 DB03017 | DB03017 | |
| 0.001 | 0.731 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.009 DB03017 | DB03017 | |
| 0.006 | 0.737 | 0.277 | GABA aminotransferase inhibitor | 0.277 0.004 DB03017 0.1 0.027 DBMET00531 | DB03017 | |
| 0.003 | 0.734 | 0.1 | Prostaglandin-E synthase inhibitor | 0.1 0.027 DB03017 | DB03017 | |
| 0.005 | 0.737 | 0.244 | NMDA receptor agonist | 0.244 0.004 DB03017 0.074 0.033 DBMET00531 | DB03017 | |
| 0.009 | 0.742 | 0.309 | UDP-glucose 4-epimerase inhibitor | 0.227 0.015 DB03017 0.309 0.01 DBMET00531 | DBMET00531 | |
| 0.003 | 0.737 | 0.083 | Glutamate (mGluR3) agonist | 0.083 0.003 DB03017 0.039 0.01 DBMET00531 | DB03017 | |
| 0.003 | 0.742 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DB03017 0.1 0.031 DBMET00531 | DB03017 | |
| 0.002 | 0.742 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.036 0.004 DB03017 0.023 0.011 DBMET00531 | DB03017 | |
| 0.012 | 0.753 | 0.504 | Triose-phosphate isomerase inhibitor | 0.504 0.002 DB03017 0.274 0.005 DBMET00531 | DB03017 | |
| 0.002 | 0.748 | 0.447 | Phosphofructokinase-1 inhibitor | 0.447 0.003 DB03017 0.205 0.011 DBMET00531 | DB03017 | |
| 0 | 0.746 | 0.011 | Integrin alpha5beta6 antagonist | 0.011 0.003 DB03017 | DB03017 | |
| 0.021 | 0.768 | 0.181 | Hexokinase inhibitor | 0.181 0.048 DB03017 0.142 0.088 DBMET00531 | DB03017 | |
| 0.011 | 0.759 | 0.201 | Adenylate cyclase inhibitor | 0.201 0.025 DB03017 0.096 0.088 DBMET00531 | DB03017 | |
| 0.012 | 0.761 | 0.103 | Exportin-1 inhibitor | 0.09 0.015 DB03017 0.103 0.008 DBMET00531 | DBMET00531 | |
| 0.001 | 0.752 | 0.435 | Fumarate hydratase inhibitor | 0.435 0.002 DB03017 0.086 0.006 DBMET00531 | DB03017 | |
| 0.003 | 0.755 | 0.054 | Histamine H1 receptor agonist | 0.054 0.013 DBMET00531 | DBMET00531 | |
| 0.006 | 0.759 | 0.123 | M17 leucyl aminopeptidase inhibitor | 0.123 0.075 DB03017 | DB03017 | |
| 0.004 | 0.764 | 0.08 | HCV NS3/NS4A protease inhibitor | 0.08 0.011 DB03017 | DB03017 | |
| 0.008 | 0.772 | 0.199 | Mannose-6-phosphate isomerase inhibitor | 0.175 0.046 DB03017 0.199 0.031 DBMET00531 | DBMET00531 | |
| 0.003 | 0.768 | 0.541 | Glutamate decarboxylase inhibitor | 0.541 0.002 DB03017 0.165 0.011 DBMET00531 | DB03017 | |
| 0.001 | 0.768 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET00531 | DBMET00531 | |
| 0.004 | 0.773 | 0.117 | Carbonic anhydrase VA inhibitor | 0.117 0.019 DB03017 0.066 0.051 DBMET00531 | DB03017 | |
| 0.001 | 0.77 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.007 DB03017 0.021 0.01 DBMET00531 | DB03017 | |
| 0.001 | 0.772 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | 0.064 0.015 DB03017 | DB03017 | |
| 0.012 | 0.784 | 0.134 | Carbonic anhydrase XV inhibitor | 0.132 0.038 DB03017 0.134 0.038 DBMET00531 | DBMET00531 | |
| 0.009 | 0.782 | 0.208 | Thiol protease inhibitor | 0.208 0.036 DB03017 | DB03017 | |
| 0.018 | 0.791 | 0.117 | Transcription factor STAT6 inhibitor | 0.117 0.065 DB03017 0.111 0.077 DBMET00531 | DB03017 | |
| 0.001 | 0.774 | 0.034 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 DBMET00531 | DBMET00531 | |
| 0.003 | 0.776 | 0.062 | Oxytocin agonist | 0.062 0.015 DB03017 0.052 0.022 DBMET00531 | DB03017 | |
| 0.003 | 0.778 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.029 0.003 DB03017 0.022 0.006 DBMET00531 | DB03017 | |
| 0.005 | 0.78 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.041 DBMET00531 | DBMET00531 | |
| 0.003 | 0.779 | 0.069 | Calcitonin receptor agonist | 0.069 0.013 DB03017 0.029 0.028 DBMET00531 | DB03017 | |
| 0.004 | 0.78 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DB03017 0.059 0.017 DBMET00531 | DBMET00531 | |
| 0.003 | 0.779 | 0.022 | ICAM 1 antagonist | 0.022 0.018 DB03017 | DB03017 | |
| 0.001 | 0.779 | 0.054 | Carbonic anhydrase IV inhibitor | 0.054 0.022 DB03017 | DB03017 | |
| 0.002 | 0.78 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.024 DB03017 | DB03017 | |
| 0.013 | 0.793 | 0.229 | NADH dehydrogenase inhibitor | 0.225 0.009 DB03017 0.229 0.009 DBMET00531 | DBMET00531 | |
| 0.002 | 0.783 | 0.915 | Alcohol oxidase inhibitor | 0.812 0.003 DB03017 0.915 0.002 DBMET00531 | DBMET00531 | |
| 0.003 | 0.787 | 0.06 | Dihydroorotase inhibitor | 0.06 0.016 DB03017 0.042 0.035 DBMET00531 | DB03017 | |
| 0.005 | 0.79 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET00531 | DBMET00531 | |
| 0.001 | 0.786 | 0.295 | Ornithine carbamoyltransferase inhibitor | 0.295 0.004 DB03017 0.101 0.016 DBMET00531 | DB03017 | |
| 0.025 | 0.811 | 0.095 | CC chemokine 5 receptor agonist | 0.087 0.044 DB03017 0.095 0.028 DBMET00531 | DBMET00531 | |
| 0.014 | 0.802 | 0.547 | Peroxidase inhibitor | 0.547 0.006 DB03017 0.456 0.014 DBMET00531 | DB03017 | |
| 0.006 | 0.794 | 0.069 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.069 0.005 DB03017 0.067 0.005 DBMET00531 | DB03017 | |
| 0.009 | 0.798 | 0.514 | Glutamate dehydrogenase inhibitor | 0.514 0.003 DB03017 0.176 0.012 DBMET00531 | DB03017 | |
| 0.001 | 0.791 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.01 DB03017 | DB03017 | |
| 0.009 | 0.8 | 0.349 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.349 0.013 DB03017 0.243 0.046 DBMET00531 | DB03017 | |
| 0.002 | 0.795 | 0.021 | Factor XIII inhibitor | 0.021 0.014 DBMET00531 | DBMET00531 | |
| 0.018 | 0.811 | 0.178 | CF transmembrane conductance regulator agonist | 0.178 0.038 DB03017 0.174 0.043 DBMET00531 | DB03017 | |
| 0.003 | 0.797 | 0.042 | Glutamate (mGluR4) agonist | 0.042 0.014 DB03017 | DB03017 | |
| 0.006 | 0.801 | 0.574 | Ferrochelatase inhibitor | 0.574 0.002 DB03017 0.378 0.004 DBMET00531 | DB03017 | |
| 0 | 0.795 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET00531 | DBMET00531 | |
| 0.015 | 0.812 | 0.189 | 3C-like protease (Human coronavirus) inhibitor | 0.189 0.059 DBMET00531 | DBMET00531 | |
| 0.001 | 0.8 | 0.021 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 DBMET00531 | DBMET00531 | |
| 0.009 | 0.808 | 0.286 | Aminopeptidase B inhibitor | 0.286 0.009 DB03017 0.171 0.03 DBMET00531 | DB03017 | |
| 0.004 | 0.805 | 0.134 | Beta amyloid protein antagonist | 0.134 0.053 DB03017 | DB03017 | |
| 0.003 | 0.808 | 0.7 | Porphobilinogen synthase inhibitor | 0.7 0.002 DB03017 0.263 0.007 DBMET00531 | DB03017 | |
| 0.001 | 0.809 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET00531 | DBMET00531 | |
| 0.001 | 0.809 | 0.133 | Ribonucleoside-diphosphate reductase inhibitor | 0.133 0.014 DB03017 | DB03017 | |
| 0.001 | 0.811 | 0.13 | Ribonucleotide reductase inhibitor | 0.13 0.015 DB03017 | DB03017 | |
| 0.003 | 0.813 | 0.122 | Glutamate (mGluR1) agonist | 0.122 0.003 DB03017 0.026 0.014 DBMET00531 | DB03017 | |
| 0.012 | 0.822 | 0.063 | Carbonic anhydrase II stimulant | 0.063 0.02 DB03017 | DB03017 | |
| 0.005 | 0.818 | 0.177 | Pyruvate kinase inhibitor | 0.177 0.095 DB03017 | DB03017 | |
| 0.001 | 0.816 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 DB03017 0.064 0.008 DBMET00531 | DB03017 | |
| 0.001 | 0.816 | 0.086 | Urate transporter 1 inhibitor | 0.086 0.007 DB03017 | DB03017 | |
| 0.004 | 0.82 | 0.076 | Adenosine A3 receptor antagonist | 0.076 0.048 DB03017 | DB03017 | |
| 0 | 0.817 | 0.041 | Aminopeptidase A inhibitor | 0.041 0.004 DB03017 | DB03017 | |
| 0.01 | 0.828 | 0.098 | mTOR complex 2 inhibitor | 0.086 0.055 DB03017 0.098 0.035 DBMET00531 | DBMET00531 | |
| 0.005 | 0.825 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.057 DBMET00531 | DBMET00531 | |
| 0.008 | 0.83 | 0.23 | Cathepsin H inhibitor | 0.23 0.016 DB03017 0.156 0.042 DBMET00531 | DB03017 | |
| 0.011 | 0.834 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | 0.193 0.013 DB03017 0.139 0.03 DBMET00531 | DB03017 | |
| 0 | 0.825 | 0.026 | Telomerase stimulant | 0.026 0.004 DB03017 0.024 0.005 DBMET00531 | DB03017 | |
| 0.001 | 0.831 | 0.099 | Lysine carboxypeptidase inhibitor | 0.099 0.004 DB03017 0.03 0.016 DBMET00531 | DB03017 | |
| 0.006 | 0.839 | 0.735 | Alpha-N-acetylglucosaminidase inhibitor | 0.735 0.003 DB03017 0.619 0.004 DBMET00531 | DB03017 | |
| 0.001 | 0.836 | 0.028 | MAP3K8 inhibitor | 0.028 0.024 DBMET00531 | DBMET00531 | |
| 0.004 | 0.841 | 0.035 | Carbonic anhydrase I stimulant | 0.035 0.03 DB03017 | DB03017 | |
| 0.004 | 0.841 | 0.075 | Fatty acid synthase inhibitor | 0.075 0.022 DB03017 | DB03017 | |
| 0.001 | 0.838 | 0.048 | Nicotinic acid receptor 2 antagonist | 0.048 0.004 DB03017 0.034 0.009 DBMET00531 | DB03017 | |
| 0 | 0.839 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DB03017 | DB03017 | |
| 0.005 | 0.844 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DB03017 0.079 0.037 DBMET00531 | DBMET00531 | |
| 0 | 0.84 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.005 DB03017 0.019 0.01 DBMET00531 | DB03017 | |
| 0.007 | 0.847 | 0.184 | DOPA decarboxylase inhibitor | 0.184 0.009 DB03017 0.166 0.015 DBMET00531 | DB03017 | |
| 0.002 | 0.844 | 0.361 | Argininosuccinate synthase inhibitor | 0.361 0.003 DB03017 0.157 0.011 DBMET00531 | DB03017 | |
| 0.002 | 0.846 | 0.052 | Carboxypeptidase B inhibitor | 0.052 0.006 DB03017 | DB03017 | |
| 0.003 | 0.848 | 0.252 | Histidine decarboxylase inhibitor | 0.252 0.009 DB03017 0.16 0.018 DBMET00531 | DB03017 | |
| 0.001 | 0.848 | 0.133 | Glutamate (mGluR1a) agonist | 0.133 0.003 DB03017 0.039 0.006 DBMET00531 | DB03017 | |
| 0.007 | 0.854 | 0.151 | Purinergic P2X1 antagonist | 0.151 0.007 DB03017 0.11 0.014 DBMET00531 | DB03017 | |
| 0.001 | 0.848 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DB03017 | DB03017 | |
| 0.006 | 0.856 | 0.215 | Keratolytic | 0.215 0.007 DB03017 0.096 0.033 DBMET00531 | DB03017 | |
| 0.001 | 0.852 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DBMET00531 | DBMET00531 | |
| 0.013 | 0.866 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.115 DB03017 | DB03017 | |
| 0.004 | 0.861 | 0.733 | GABA C receptor agonist | 0.733 0.002 DB03017 0.497 0.004 DBMET00531 | DB03017 | |
| 0.002 | 0.86 | 0.288 | Biliverdin reductase inhibitor | 0.288 0.003 DB03017 0.19 0.006 DBMET00531 | DB03017 | |
| 0.001 | 0.859 | 0.034 | Diamine oxidase inhibitor | 0.034 0.031 DBMET00531 | DBMET00531 | |
| 0.003 | 0.862 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 DB03017 0.037 0.022 DBMET00531 | DB03017 | |
| 0.002 | 0.861 | 0.063 | Histamine H2 receptor agonist | 0.041 0.032 DB03017 0.063 0.013 DBMET00531 | DBMET00531 | |
| 0.011 | 0.871 | 0.071 | Transcription factor RelA inhibitor | 0.071 0.028 DBMET00531 | DBMET00531 | |
| 0.002 | 0.863 | 0.142 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.121 0.011 DB03017 0.142 0.009 DBMET00531 | DBMET00531 | |
| 0.004 | 0.866 | 0.145 | I kappa B kinase epsilon inhibitor | 0.145 0.125 DBMET00531 | DBMET00531 | |
| 0.002 | 0.868 | 0.059 | Aryl hydrocarbon receptor antagonist | 0.059 0.056 DBMET00531 | DBMET00531 | |
| 0.003 | 0.869 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.058 0.032 DB03017 0.069 0.022 DBMET00531 | DBMET00531 | |
| 0 | 0.867 | 0.046 | Glutamate (mGluR6) agonist | 0.046 0.002 DB03017 0.017 0.005 DBMET00531 | DB03017 | |
| 0.003 | 0.874 | 0.11 | Nitric-oxide synthase inhibitor | 0.11 0.046 DB03017 | DB03017 | |
| 0.012 | 0.883 | 0.125 | MAP kinase 3 inhibitor | 0.125 0.121 DBMET00531 | DBMET00531 | |
| 0.003 | 0.876 | 0.209 | Aminopeptidase I inhibitor | 0.209 0.006 DB03017 0.131 0.016 DBMET00531 | DB03017 | |
| 0.035 | 0.91 | 0.279 | Nitric-oxide synthase stimulant | 0.23 0.049 DB03017 0.279 0.018 DBMET00531 | DBMET00531 | |
| 0.001 | 0.878 | 0.062 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 DBMET00531 | DBMET00531 | |
| 0.007 | 0.885 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DB03017 0.064 0.017 DBMET00531 | DBMET00531 | |
| 0.002 | 0.88 | 0.265 | Phenylalanine 4-hydroxylase inhibitor | 0.265 0.004 DB03017 0.141 0.013 DBMET00531 | DB03017 | |
| 0.003 | 0.881 | 0.118 | Glutamate (mGluR8) agonist | 0.118 0.002 DB03017 0.067 0.005 DBMET00531 | DB03017 | |
| 0.002 | 0.884 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 DB03017 0.025 0.022 DBMET00531 | DBMET00531 | |
| 0.001 | 0.884 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 DB03017 0.044 0.005 DBMET00531 | DBMET00531 | |
| 0.006 | 0.892 | 0.09 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DB03017 0.09 0.024 DBMET00531 | DBMET00531 | |
| 0.002 | 0.889 | 0.055 | Potassium channel (Inward rectifier) activator | 0.052 0.032 DB03017 0.055 0.027 DBMET00531 | DBMET00531 | |
| 0.002 | 0.89 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.049 0.031 DB03017 0.052 0.027 DBMET00531 | DBMET00531 | |
| 0.002 | 0.893 | 0.045 | Integrin alpha2 antagonist | 0.045 0.015 DB03017 0.034 0.031 DBMET00531 | DB03017 | |
| 0.002 | 0.895 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DB03017 0.101 0.013 DBMET00531 | DBMET00531 | |
| 0.003 | 0.896 | 0.093 | AICAR transformylase inhibitor | 0.093 0.005 DB03017 0.048 0.024 DBMET00531 | DB03017 | |
| 0.002 | 0.898 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00531 | DBMET00531 | |
| 0.006 | 0.908 | 0.232 | Hemostatic | 0.232 0.024 DB03017 | DB03017 | |
| 0.002 | 0.907 | 0.111 | CYP2A6 inhibitor | 0.073 0.056 DB03017 0.111 0.031 DBMET00531 | DBMET00531 | |
| 0.001 | 0.908 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.026 DB03017 | DB03017 | |
| 0.005 | 0.912 | 0.074 | Dihydroorotate oxidase inhibitor | 0.06 0.029 DB03017 0.074 0.014 DBMET00531 | DBMET00531 | |
| 0.006 | 0.915 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET00531 | DBMET00531 | |
| 0.003 | 0.915 | 0.041 | Potassium channel Kv1.1 blocker | 0.041 0.021 DBMET00531 | DBMET00531 | |
| 0.004 | 0.918 | 0.049 | Aldosterone antagonist | 0.049 0.03 DB03017 0.048 0.032 DBMET00531 | DB03017 | |
| 0 | 0.919 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 DBMET00531 | DBMET00531 | |
| 0.002 | 0.927 | 0.03 | Complement factor 1s inhibitor | 0.024 0.021 DB03017 0.03 0.008 DBMET00531 | DBMET00531 | |
| 0.002 | 0.932 | 0.117 | Inducible nitric-oxide synthase inhibitor | 0.117 0.026 DB03017 | DB03017 | |
| 0.002 | 0.938 | 0.158 | Carbonic anhydrase stimulant | 0.158 0.01 DB03017 0.066 0.035 DBMET00531 | DB03017 | |
| 0.002 | 0.941 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.037 DB03017 | DB03017 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |